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Atherosclerosis is a multifactorial inflammatory disease that occurs in 
predisposed locations in the vasculature where blood flow is disturbed.  In vitro studies 
have implicated reactive oxygen species as important mediators of pathologic WSS 
signaling.  In vitro studies have implicated reactive oxygen species as mediators of 
mechanotransduction leading to inflammatory protein expression and ultimately 
atherogenesis.  While these cell culture-based studies have provided enormous insight 
into the effects of WSS on endothelial biology, the applicability to the normal, in vivo 
setting is questionable.  We hypothesized that low magnitude oscillatory WSS acts 
through ROS to increase expression of inflammatory cell adhesion molecules leading to 
the development of atherosclerotic lesions.  The overall objective for this thesis was to 
develop an in vivo flow model in the mouse that produces low magnitude oscillatory wall 
shear stress which could be used to investigate the in vivo molecular mechanisms of 
mechanotransduction.   
We created a novel aortic coarctation model using a shape memory nitinol clip.  
The clip reproducibly constricts the aorta creating a narrowing of the lumen resulting in a 
stenosis.  This mechanical constraint produces a region of flow separation downstream 
from the coarctation.  We have characterized the coarctation in terms of the efficacy, 
pressure loss, and fluid dynamics.  We then measured the endothelial response of shear 
sensitive redox and inflammatory markers.  Lastly, we utilized genetically modified mice 
and mice treated with pharmacological inhibitors to investigate the mechanisms involved 
in the expression of WSS induced inflammatory and redox markers.   
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We found that inducing a coarctation of the aorta using a nitinol clip uniquely 
created a hemodynamic environment of low magnitude oscillatory WSS without a 
significant change in blood pressure.  Using this model we found that the in vivo 
endothelial phenotype associated with acutely disturbed flow was characterized by 
increased production of superoxide and increased expression of select inflammatory 
proteins.  In comparison, the phenotype associated with chronically disturbed flow was 
characterized by a more modest increase in superoxide and increased levels of multiple 
inflammatory proteins.  We determined that in regions of acutely disturbed flow in vivo, 
VCAM-1 expression was not modulated by reactive oxygen species.  Additionally, p47 
phox-dependent NADPH Oxidase activity does not have a functional role in WSS 
induced superoxide generation in the endothelium.  
In summary, we have created a novel murine model of low magnitude oscillatory 
WSS that can be used to investigate the in vivo molecular mechanisms associated with 
atherogenesis. While previous data obtained in vitro indicated that depletion of an 
individual ROS was sufficient to inhibit flow-induced inflammatory protein expression, 
our findings, to the contrary, showed that antioxidant treatment in vivo does not inhibit 
shear-dependent inflammatory protein expression.  Our results suggest that atherogenesis 
in the in vivo environment is significantly more complicated than the in vitro 
environment and that parallel pathways and compensatory mechanisms are likely 
activated in vivo in response to WSS.  These results could have significant implications in 
the efficacy of antioxidant treatment of atherosclerosis and could explain the complexity 




SPECIFIC AIMS  
Atherosclerosis is a multifactorial inflammatory disease of the vasculature that 
develops over many years.  It is the underlying cause of numerous other cardiovascular 
diseases, notably myocardial infarction and stroke.  These diseases are the leading cause 
of morbidity and mortality in the United States as well as a major financial burden on our 
society [1-3].  Significant resources, have therefore, gone into the research and 
understanding of the pathogenesis of atherosclerosis.  Numerous risk factors for 
atherosclerosis have been identified such as age, smoking, obesity, genetics, diabetes, 
hypelipidemia, and hypertension.  These risk factors are considered systemic risk factors; 
however, atherosclerosis is a focal disease that occurs in specific predisposed locations in 
the vasculature.    
Specific hemodynamic conditions have been correlated to the localization of 
atherosclerotic lesion formation.  These conditions uniquely occur in regions of disturbed 
blood flow where there is low magnitude oscillatory WSS.  The majority of studies on the 
effects of WSS on endothelial biology have involved cell culture-based studies.  The 
obvious and significant advantage of these systems is the ability to carefully regulate both 
the hemodynamic and biological environments.  Research using these systems has 
generated a wealth of productive studies.  These studies have shown that low and/or 
oscillatory WSS is associated with pro-atherogenic factors including oxidative stress, 
VCAM-1 expression, and uncoupled eNOS, among others.  In vitro studies have 
specifically identified ROS as important mediators of pathologic WSS signaling.  ROS 
have been shown to mediate the activation of the NFκB transcription factor and 
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subsequently inflammatory cell adhesion molecule expression.  Conversely, physiologic, 
“high” shear stress has been associated with atheroprotective factors such as increased 
eNOS expression, increased expression of antioxidant enzymes and resultant increased 
concentrations of bioavailable NO.   
While these cell culture-based studies have provided enormous insight into the 
effects of WSS on endothelial biology, the applicability to the normal, in vivo setting is 
questionable.  Initial in vivo studies have shown correlations between pro-atherogenic 
factors and regions predisposed to atherosclerosis. However, the characterization of shear 
stress in the intact animal is extremely complex, and studies of these pro-atherogenic 
regions have been difficult and limited.  It is imperative to develop more comprehensive 
in vivo shear stress models in order to definitively assess the applicability of these in vitro 
data to the in vivo setting.  We hypothesized that low magnitude oscillatory WSS acts 
through ROS to increase expression of inflammatory cell adhesion molecules leading to 
the development of atherosclerotic lesions.   
Specific Aim 1 
Develop an acute mouse aortic coarctation model  
Our first objective was to develop an in vivo coarctation model of controlled 
hemodynamic conditions in which we can quantitatively assess expression of pro-
inflammatory gene products that have been linked to atherogenesis.  Our model 
overcomes the limitations of previous flow models by inducing a precisely defined 
coarctation in the suprarenal region of the aorta using a shape memory nitinol clip.  We 
used µCT and MRI techniques to obtain boundary conditions for a computational fluid 
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dynamic model.  Using our CFD in silico model we characterized the hemodynamic 
environment associated with our in vivo coarctation model.  
Specific Aim 2 
Identify the expression of inflammatory markers in the mouse coarctation model 
Our objective for specific aim 2 was to quantitatively measure the acute response 
of atherogenic markers in the region of low magnitude oscillatory WSS.  We 
hypothesized that inflammatory proteins would increase in the region of low magnitude 
oscillatory WSS.  We quantitatively measured expression of VCAM-1 and ICAM-1 using 
quantum dot nanoparticles with immunohistochemical techniques and also measured 
superoxide levels using the novel superoxide sensitive dye, hydro-Cy3.  Additionally, we 
were able to compare differences between the acute response, on the order of days, and 
chronic response, on the order of months.  The acute response was measured downstream 
from the coarctation while the chronic response was measured in the aortic arch.   
Specific Aim 3 
Investigate redox signaling mechanisms in the mouse coarctation model 
Our final objective was to investigate the signaling mechanisms by which ROS 
mediate WSS transduction to induce inflammatory marker signaling using a combination 
of genetic models and pharmacological inhibitors.  We hypothesized that atherogenic 
markers would increase in a ROS dependent manner in response to disturbed flow.  To 
analyze this hypothesis we employed a combination of transgenic animals and 
pharmacological inhibitors to alter ROS signaling pathways with our coarctation model.  
We then measured VCAM-1 expression in these animal models.  We found that 
inflammatory protein expression increased in response to acutely induced low magnitude 
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WSS and that decreased ROS levels were not sufficient to attenuate this response.  This 
suggests that parallel pathways or compensatory mechanisms may be acting in this in 
vivo model.   
Significance and Innovation 
Research into the molecular mechanisms involved in the pathogenesis of 
atherosclerosis will lead to advancements in therapeutics to treat the leading cause of 
morbidity and mortality in the United States.  Atherosclerosis develops at specific regions 
of the vasculature where the hemodynamics produce low magnitude oscillatory WSS.  
The endothelium transduces these stresses into biochemical signals leading to an 
endothelial phenotype that is susceptible to atherosclerosis development.  Most research 
into the molecular mechanisms involving mechanotransduction pathways is limited to 
cell culture studies due to the lack of simple in vivo flow models.  We present a novel in 
vivo flow model that makes significant advances over the complex and challenging in 
vivo flow models currently available.  
The coarctation model presented in this thesis utilizes a novel shape memory clip 
to reliably induce a narrowing of the aorta.  By utilizing the shape memory properties of 
nitinol we are able to obtain consistent recovery of the clip and thus induce a consistent 
coarctation.  This technique minimizes variability due to human surgical error.  We 
validate the efficacy of this technique using in vivo, ex vivo, and in situ imaging 
modalities.  Current flow models are often poorly characterized and in particular tend to 
lack pressure measurements.  We use innovative new techniques to validate morphology, 
flow, and pressure through direct measurements and then model the various mechanical 
forces that are applied to the endothelium.   
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We complement our novel in vivo flow model with novel histological imaging 
techniques.  Quantum dot based immunohistochemistry quantitatively measures 
inflammatory protein expression.  Quantum dots are highly stable fluorophores that do 
not photobleach.  Additionally, they have a very narrow emission spectrum thus 
minimizing the signal to noise ratio.  We apply these to an en face technique that 
uniquely allows for a highly quantitative analysis of regional expression levels of various 
inflammatory proteins.  We also use novel superoxide sensitive fluorophore, hydro-Cy3, 
recently developed by our collaborators.  Superoxide staining has been limited to the use 
of the highly unstable fluorophore, DHE.  Hydrocyanines present a new class of 
superoxide sensitive fluorophores that are significantly more stable than DHE.  This 
allows for improved quantitative measurements and staining in a wider variety of tissue 
preparations, including en face aorta preparations.  We present a novel use for hydro-Cy3 
in which we are able to measure regional endothelial superoxide levels. 
Lastly, in our third aim, we analyze the in vivo contribution of WSS stimulated 
ROS to inflammatory protein expression.  The role of ROS in various stages of lesion 
development is currently unclear.  Using our aortic coarctation model with a combination 
of transgenic animals, knockout animals, and pharmacological inhibitors, we investigate 
the ROS dependent molecular mechanisms that mediate inflammatory protein expression.   
This study investigates the applicability of pathways already identified in vitro to the 
overall pathogenesis of atherosclerosis.   The insight gained from this study will lead to 
improved knowledge about the timing of treatment of atherosclerosis, specifically with 




BACKGROUND AND LITERATURE REVIEW  
Cardiovascular Disease Epidemiology 
CVD is the leading cause of morbidity and mortality in the United States.  It has 
been estimated that CVD is present in 81 million Americans, slightly more than one third 
of the adult population [1, 2].  The top four presentations of CVD include: high blood 
pressure (74.5 million people), coronary heart disease (17.6 million people), heart failure 
(5.8 million people), and stroke (6.4 million people) [1, 2].  It is important to note that 
many people have two or more forms of CVD.  Both coronary heart disease and stroke 
are products of atherosclerotic CVD and hypertension is a leading risk factor for the 
development of atherosclerotic lesions.    The prevalence of CVD in males is at 37.1% of 
the population while prevalence in females is at 36.6%.  CVD accounted for 871,517 
deaths in 2006, 34.1% of all mortality [3].    There are large prevalence discrepancies in 
the racial distribution of disease.  African American males have the highest CVD death 
rate of 422.8 (per 100,000), compared to 220.1 for white males and 136.3 for Asian males 
[3].  These diseases cost the country an estimated $431 billion in direct and indirect costs 
each year, presenting a significant burden on the country [2].  Though CVD is the leading 
cause of death, the age adjusted rate of death has been decreasing since the 1970s.  
Continued research into the pathogenesis of CVD will lead to novel therapeutics and help 
continue this trend. 
Atherosclerosis Pathology 
Atherosclerosis is an inflammatory disease of the cardiovascular system that is 
predisposed to specific locations in the vasculature [4-6].  Though the disease is 
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considered a systemic disease, advanced lesions develop in specific locations within the 
vasculature including: the coronary arteries, the carotid bifurcation, the abdominal aorta, 
and some peripheral arteries.  Many systemic risk factors for atherosclerosis development 
have been identified; however, the focal development of plaque formation is most 
strongly correlated to disturbed flow and the resultant low and/or oscillatory WSS.  
Lesion formation is a multifactoral process that occurs through a combination of 
biochemical and biomechanical factors.    
The AHA has characterized 6 stages of lesion development ranging from a 
healthy vessel to a complex lesion [7-9].  The initial stage is characterized by leukocyte 
recruitment leading to intimal thickening as well as intracellular lipid deposition and 
oxidation.  It is this stage where the initial localization of the disease is initiated by 
disturbed blood flow.  At the interface between the blood and the vascular wall, the 
endothelium acts as a sensor of WSS.  The endothelium converts WSS into biochemical 
signals, which results in either a maintained state of vascular homeostasis under 
physiologic WSS levels or a shift toward endothelial dysfunction and atherogenesis under 
low and/or oscillatory WSS [10].  Mechano-sensitive pathways have been implicated as 
important mediators in regulating the inflammatory response of the endothelium, initially 
through modulation of genetic transcription factors, the redox state, and subsequent 
expression of inflammatory cell adhesion molecules.  This process leading to lesion 
localization is highly dependent on complex in vivo flow behavior and the associated 
WSS, whereas the progression of the disease is believed to involve more systemic factors 
(figure 2.1). 
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The second stage is characterized by fatty streak formation.  During this stage 
there is increased lipid deposition leading to foam cell formation.  Additionally, there is 
adaptive intimal thickening.  The next stage is an intermediate lesion with a fatty plaque 
or raised fatty streak.  This is primarily characterized by lipid pools, though no lipid core 
is present.  The fourth stage is an atheroma with the beginnings of a fibrous plaque.  This 
stage is characterized by the development of a lipid core.  Atheromas have high levels of 
connective tissue that develop in the intimal extracellular matrix; the ECM is largely 
composed of collagen, proteoglycan, fibronectin, and elastin fibers.  The fifth stage is a 
fibroatheroma.  In this stage there can be a variety of presentations including multiple 
lipid cores, a fibrotic cap, plaque vasscularization, or calcification.  Histology has shown 
that plaques with thin fibrotic caps and proteoglycan rich erosion sites are vulnerable to 
rupture and therefore a cardiovascular event.  The last stage is a complicated lesion which 
often presents as a ruptured or eroded plaque.  These lesions can have the characteristics 
of a stage five fibroatheroma along with hemorrhage or thrombosis.  Patients with 
complicated lesions often present with a cardiovascular event and therefore intervention 
is often recommended.   
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Figure 2.1 – Atherosclerotic Lesion Formation – A) healthy blood vessel.  B) 
Endothelial dysfunction.  Endothelium expresses adhesion molecules and becomes 
increasingly permeable.  Leukocytes bind to the endothelium then migrate into the vessel 
wall.  C) Neointima formation.  Smooth muscle cells migrate into the intima, t cells 
become activated, and monocytes become foam cells.  D)  Advanced plaque formation.  
This stage can manifest itself in a variety of ways, shown in this figure: a fibrous cap 
forms over the lesion, a necrotic core forms, and macrophages accumulate.  E)  Plaque 
rupture.  The fibrous cap thins eventually leading to plaque rupture.  When this occurs, a 
thrombus can form leading to a myocardial infarction or stroke. Image adapted with 
permission from [6] 
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Flow in the Vasculature 
Fluid Mechanics of Physiologic Flow 
 Atheroma formation is highly dependent on flow conditions in vivo that vary in 
different locations in the vasculature due to the boundary conditions imposed on the flow, 
namely inlet/outlet conditions and morphologic constraints.  Flow conditions throughout 
most of the major arteries can be characterized as pulsatile and viscous and often fully 
developed.  Two non-dimensional terms that are derived from an analysis of the Navier-
Stokes equation are used to characterize these flow patterns: the Reynolds number and 












Where Re is the Reynolds number, µ is the viscosity, D is the diameter of the vessel, ρ is 
the density, υ is the kinematic viscosity, ω is the angular frequency, and R is the radius of 
the vessel.  The Reynolds number is a measure of the stability of flow, relating inertial 
fluid momentum to the viscous frictional force.  High Reynolds numbers correspond to 
flow dependent on momentum effects while low Reynolds numbers correspond to flow 
dependent on viscosity.  The Reynolds number describes the stability of flow; laminar 
flow occurs at Reynolds numbers between 0 and approximately 2,300 at which point flow 
transitions to a turbulent state.  In the vasculature, Reynolds numbers vary from 1 in 
small peripheral arteries to approximately 4000 in the aorta [12].  Therefore, flow can 
vary from laminar to turbulent and each artery must be examined individually to 
determine flow stability.   
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The Womersely number is a non-dimensional parameter of the pulsatility of flow. 
It relates the contributions of unsteady forces to viscous forces.  At low Womersley 
numbers, viscous flows dominate, while high Womersley numbers correspond to flow 
dependent on inertial forces.  The Womersley parameter characterizes the shape of the 
velocity profile where low Womersley numbers have a parabolic profile and high 
Womersley numbers have a flat, blocky, profile.  Most Womersley numbers in the 
vasculature are in an intermediate range, between 1 and 10, and have flow profiles that 
vary depending on the location in the vasculature.  Both the Reynolds number and the 
Womersley number will have large effects on the WSS acting on the endothelium [12].  
The WSS acting on endothelial cells is governed by fluid dynamic principles, which 




Variables are the same as above and U is the velocity.  WSS under normal physiologic 
conditions is therefore dependent on dU/dr and the velocity profile.  The velocity profile 
can vary between a blunt profile, where dU/dr at the wall will be relatively high, or a 
parabolic profile, where dU/dr at the wall will be moderate.  The profile will be highly 
dependent on the location in the vasculature; however, on average, the vasculature in 
humans maintains a physiologic mean WSS around 15 dynes/cm2 [12, 13].  Under 
physiologic flow conditions, WSS is relatively high, and the endothelial signaling is 
atheroprotective.   
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Disturbed Flow In Vivo 
Blood flow can become disturbed by the pulsatility of blood flow as well as 
atypical geometric regions such as branch points, regions of high curvature, and stenoses.  
Disturbances of flow are commonly associated with secondary flow patterns and flow 
reversal resulting in non-physiologic flow.  The WSS that is generated by disturbed flow 
is often low or even oscillatory.  Regions of disturbed flow are predisposed to 
atherosclerosis formation.  Atherosclerosis is commonly found in the coronary arteries, 
the carotid arteries and the infrarenal aorta [12].  Each region is characterized by 
disturbed flow that produces low magnitude oscillatory WSS.  Though the principles 
behind the flow disturbances are the same the actual manifestation is unique to each 
region.   
The carotid arteries are the simplest and most commonly characterized region of 
atherosclerostic lesion formation [5, 12, 14].  The carotid sinus is a unique anatomical 
region in the vasculature in which the artery has a normal out-pouching at a branching 
site.  This results in a large expansion region where the distal vessel has a larger cross 
sectional area as compared to the proximal vessel.  During the downstroke of systole, a 
negative pressure differential is created resulting in the separation of flow.  This produces 
a reversal in flow at the outer wall, opposite the flow divider.  Due to this unique 
anatomical feature, the carotid sinus is exposed to low magnitude oscillatory WSS 
resulting in a predisposition to atherosclerotic lesion formation. 
The infrarenal aorta does not have an atypical geometric region, but is 
characterized by triphasic flow [12, 15].  The initial forward flow occurs from the heart 
beat which creates a positive pressure differential between the abdominal aorta and the 
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legs.  During the middle stage of the cardiac cycle the aortic pressure begins to decline 
while the pressure in the legs increases creating a negative pressure differential and flow 
reversal.  At the end of the cardiac cycle, the pressure in the legs drops below that of the 
abdominal aorta and flow becomes positive.  There is some anterior skewing of the flow 
due to the curvature of the spine; however, the major determinant of oscillatory flow in 
the infrarenal aorta is due to to the pressure differential between the legs and abdominal 
aorta. 
The coronary arteries are another location of atherosclerotic lesion formation [12, 
16].    These arteries experience a very complex flow profile due to the contraction and 
movement of the heart.  The outlet flow is reduced during systole as the heart contracts 
and increases during diastole when the heart is relaxed, though this can vary in the 
different coronary branches.  The inlet on the other hand is at the aortic sinus resulting in 
flow that is not fully developed, a large Womersley number, and a blunt flow profile that 
is not well defined.  Furthermore, as the vessels follow the morphology of the heart, there 
are regions of high curvature.  The combination of these three features produces a 




Figure 2.2 – Disturbed Flow Profile - Flow profiles showing streamlines at a 
representative branching location in the vasculature.  Flow separation occurs in the 
shaded region opposite the flow divider.  Image adapted with permission from [17] 
Flow in a Stenosis 
A stenosis is a narrowing of the vessel lumen, commonly occuring in vivo as 
complex atheromas that progressively grow into the lumen of an artery.  However, 
induction of an artificial stenosis provides ideal conditions for WSS analysis.  Stenoses 
are defined by the percentage of stenosis (either as a relative area or diameter).  As 
atheromas progress there is a corresponding increase in percent stenosis as the lumen 
becomes smaller through the stenosis. 
Stenotic flows have predictable flow patterns.  Figure 2.3 shows streamlines 
through a stenosis.  The continuity equation predicts that in the neck region of the 
stenosis there is an increase in velocity corresponding to the decrease in area, which 
results in an increase in WSS.  Distal to the stenosis there is a jet stream in the middle of 
the lumen along with a recirculating region near the wall.  Flow separation can occur due 
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to a positive downsteam pressure gradient which can occur due to pulsatility and 













When the pressure gradient (dP/dx) is positive, conditions are favorable for flow 
separation.  This occurs during the downstroke of systole while dQ/dt is negative and in 
expansion regions where dA/dx is positive.  The threshold for separation is dependent on 
the Reynolds number, yet this equation can still predict favorable conditions for flow 
separation in the distal region to the stenosis.  The boundary layer between the jet stream 
and the recirculating region creates unstable shearing which can create turbulent 
conditions.  Turbulence can be seen in a stenosis with a significantly reduced Reynolds 
numbers, ranging from 10 to 300 depending on the degree of stenosis.  Depending on the 
degree of stenosis a wide variety of flow conditions can be obtained, including high 
WSS, low WSS, low and oscillatory WSS, and even random WSS from turbulent flows 
[12]. 
Differences between the Flow in Mice and Humans  
 Though both the mouse and the human have similar cardiovascular anatomy, 
there are some major differences that have profound effects on the blood flow.  The first 
is the obvious discrepancy in the size of the vessel.  The human aortic diameter is on the 
order of magnitude of 1 cm (usually about 2-3 cm) while the mouse aortic diameter is on 
the order of magnitude of 1 mm [18].  Considering that the velocity of the blood and the 
viscosity are the same in each animal, the equation for shear stress dictates that the wall 
shear stress imparted on the endothelium is approximately ten times higher in the mouse 
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than in the human.  This matches reported observations in the literature [18-20]. The 
Reynolds number is about ten times smaller in a mouse than a human which would 
suggest a decreased likelihood of turbulent flow in the mouse.  Additionally the 
Womersley number is about three times smaller in the mouse than the human resulting in 
a highly parabolic flow profile in the mouse.  Both these parameters suggest increased 
stability of the flow in a mouse as compared to a human.  The vessel wall is also 
dramatically different.  The thickness of the wall and the composition result in a rather 
stiff human aorta and a very elastic mouse aorta.  This results in higher dispensability in 
the mouse aorta which is believed to affect flow patterns.  One particular observation was 
that the triphasic flow profile with flow reversal in the infrarenal aorta in humans is not 
observed in the mouse [19].  This could have implications in differential disease 
development a region where human develop atherosclerosis as well as aneurysms.  An 
additional difference is that the cardiac cycle is about ten times longer in the human than 
the mouse, resulting in a human heart rate around 60 beats per minute and a mouse heart 
rate around 600 beats per minute.   
Murine Flow Models 
Mouse flow models of in vivo mechanotransduction tend to fall into two 
categories: chronic or device-based.  Chronic models utilize regions where the innate 
morphology produces chronically disturbed flow [20, 21].  CFD models of the aortic arch 
have shown that there is low mean WSS at the inner curvature of the aortic arch (figure 
2.4).  The directionality of the WSS vectors further shows that the WSS oscillates 
throughout the cardiac cycle.  These models have also identified the region opposite the 
flow divider of the brachiocephalic branch as a region of low magnitude oscillatory WSS.  
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As can be viewed in figure 2.4, the aortic arch has a very complex morphology and the 
location of disturbed flow occurs at a very precise and small region. This can make for 
challenging analysis when investigating the molecular mechanisms involved in 
mechanotransduction.  Additionally, these regions experience a chronically disturbed 
flow environment which may allow for activation of compensatory mechanisms.  Studies 
have recently described these chronically disturbed flow regions as “atherosusceptible.”  
These studies have shown that various inflammatory markers are expressed in this region 
and that they are primed for the development of atherosclerotic lesions [20].  The aortic 
sinus, is also a plausible location for disturbed flow; however, it is a very challenging 
environment to model in the mouse due to the small diameter of the vessel, the 
undeveloped flow in this region, and the moving wall of the vessel and the valve.  As of 





Figure 2.4 - CFD Model of the Aortic Arch of a Mouse - Low mean WSS was 
identified at regions a and b, while region c experiences high mean WSS.  Polar plots of 
the WSS vectors show that there is oscillatory WSS at regions a and b while region c 
experiences unidirectional WSS.  The lower panel shows lesion formation (left), in 
comparison to the CFD (middle), and VCAM-1 expression (right).  Image Adapted with 
permission from [20] 
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Device-based models of disturbed flow allow for the investigation of 
mechanotransduction over an acute time course.  This allows for the potential to separate 
the effect of compensatory mechanisms from pathways activated by direct mechanical 
transduction.  These techniques are often complicated and not fully defined in terms of 
the precise hemodynamic conditions or create flow environments that do not experience 
low magnitude oscillatory WSS.  Most device-based mouse models induce a coarctation 
using silver U-shaped clips, sutures tied around a needle, or polymer casts [22-24].  The 
initial coarctation models were used as models of upstream hypertension, utilizing first 
sutures, later refined to U shaped clips.  These models induce a severe stenosis, thereby 
creating a large pressure drop and a systemic change in hemodynamics.  These were not 
designed as models to investigate WSS based mechanotransduction and have not been 
characterized as such.  Additionally, these methods have reported high mortality rates 
[23].   
Recently a model utilizing a polymer cast to induce a coarctation was developed 
as a model of localized disturbed flow without systemic effects [25].  This model uses a 
polymer cast that is placed around the carotid artery to restrict flow and create a stenosis.  
This model reports a region of low unidirectional WSS upstream from the cast and a 
region of high magnitude oscillatory WSS downstream from the cast.  It is important to 
note some limitations with this model.  First, the region of low unidirectional WSS 
reports an average WSS of 100 dynes/cm2.  Mean WSS magnitudes in the carotid artery 
of mice have been reported to range from 31 dynes/cm2 to 144 dynes/cm2 with an 
average around 65 dynes/cm2, thus the claim that 100 dynes/cm2 as a region of low 
magnitude WSS is questionable [18].  It is plausible that another mechanical stimulus, 
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namely strain, could participate in this model; however, the study does not characterize 
the change in pressure or strain.  Another limitation is that the oscillatory region reports 
high magnitude WSS levels with an average WSS of 140 dynes/cm2 and a temporal range 
of 600 dynes/cm2.  There is no region in this model where low magnitude oscillatory 
WSS is produced.   
A new type of device-based model was recently demonstrated using a partial 
carotid ligation.  The partial carotid ligation significantly reduces the blood flow through 
the carotid artery and creates flow reversal during part of the cardiac cycle [26, 27].  
Mean WSS in this model drops from 100 dynes/cm2 to approximately 10 dynes/cm2.  The 
flow completely reverses and blood flows out of the carotid during diastole resulting in 
low magnitude oscillatory WSS.  This is a very promising model as it creates low 
magnitude oscillatory WSS, but it is important to note that there is no characterization of 
any change in pressure and/or strain.   Additionally, the pathologic response shows a 
significantly increased rate of atherosclerosis development resulting in complete 
occlusion of the vessel after three weeks.  This disease development occurs much faster 
than in chronically disturbed flow regions such as the aortic arch.  There is also 
significant adventitial remodeling and ROS production in the adventitia, suggesting that 
there may be an additional stimulus involved in this model. 
Endothelial Mechanotransduction 
 The endothelium acts as a sensor for WSS by which changes in flow can affect 
biochemical signaling in the vascular wall.  The current literature has identified four 
categories of potential mechanisms by which the endothelium transduces forces: cell-
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ECM structures, cell-cell junctions, membrane structures, and the cytoskeleton of the cell 
which potentially links the former three mechanisms.  
Membrane structures signal by activating mechanisms affecting the membrane 
potential or different phosphorylation cascades.  Ion channels, in particular calcium and 
potassium channels, can be activated transiently by WSS to induce changes in the 
membrane potential and activate signaling molecules [28-30].    Additionally, signal 
transduction can occur through phosphorylation cascades activated by tyrosine kinase 
receptors, G proteins, or kinase rich caveolae domains [31, 32].  Tyrosine kinase 
receptors, particularly VEGF-R, have shown shear dependent activation independent of 
the presence of a ligand [32-34].  Similarly, G-proteins, such as Ras GTPase, have been 
shown to activate phosphorylation cascades in a shear dependent manner [35-37].  Shear 
stress can cause these proteins to aggregate in membrane domains rich in cholesterol 
known as caveolae [38].  Interactions between molecules in the domains can result in 
further activation of phosphorylation cascades.  Recent studies have suggested that 
activation of the above mentioned membrane structures may involve signal transduction 
by the primary cilia which protrude into the lumen of the vessel [39-41].   
Cell-cell junctions show two shear dependent mechanisms.  The first acts through 
tyrosine phosphorylation of PECAM activating downstream signaling [42].  The second 
acts through adheren junctions, specifically VE Cadherin.  VE cadherin is an adhesive 
protein that interacts through an anchoring molecule, Beta-Catenin, which is linked to the 
cytoskeleton.  Forces transmitted through the cytoskeleton can therefore activate VE 
Cadherin dependent signaling. 
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Cell-ECM structures are largely composed of integrins that link the cell 
cytoskeleton to the basal lamina underneath the cell.  Forces transmitted through the 
cytoskeleton can activate phosphorylation cascades and the binding of adaptor proteins.  
These events can act as modulators affecting the transcriptional profile of the cell.   
The cytoskeleton serves as the structural support that stabilizes the cell in a given 
mechanical environment.  The cytoskeleton acts to connect the different 
mechanotransduction factors with one another.  These interactions can allow 
communication between the membrane, the cell-cell junctions, and the cell-ECM junction 
all of which can have a direct affect on the cytoskeleton itself.  Interactions between the 
cytoskeleton and integrins or focal adhesions have been shown to transduce stresses, 
resulting in cytoskeletal remodeling and conformational changes in the cell [43-45].  
These transduction mechanisms likely interact to produce different temporal responses of 
molecular pathways, remodeling through adhesion complexes and integrin complexes, 
and changes in caveolae, gap junctions, and G-proteins[46].  Although many of these 
pathways have been identified as initial mediators in shear stress mechanotansduction, 
the exact mechanisms are not completely understood. 
Mechanosensitive pathways directly affect the transcriptional profile of the 
endothelium.  Under physiologic flow conditions, a baseline physiologic profile is 
expressed and an atheroprotective homeostasis is maintained.  However, under disturbed 
flow conditions, atherogenic profiles are expressed, and, in particular, the transcription 
factor NFκB is activated and translocates to the cell nucleus.  This process has an 




Figure 2.5 – Endothelial Mechanotransduction – Shear stress can be transduced by the 
endothelium through various structures as displayed in the figure.  Membrane structures 
are on the luminal surface at the interface between the cell and the blood.  These 
structures can include ion channels, caveolae, proteoglycans, and tyrosine kinase 
receptors, among others.  Cell-ECM structures are at the basal surface and mainly 
mediated through integrins.  At the junction between cells PECAM-1 and VE cadherin 
mediate signal transduction.  The cytoskeleton serves as the mechanical scaffold for the 
cell and links the former three structures. Image adapted with permission from [47]  
Endothelial Redox State 
Redox State 
The redox state within the cell is dependent on a balance between oxidants and 
anti-oxidants.  This balance is critical to the homeostasis of the vasculature and 
physiologic processes particularly with relation to the molecule NO.  NO is a potent 
vasodilator that is involved in regulating vascular tone.  Changes in the oxidative state 
can alter the NO response leading to endothelial dysfunction and eventually hypertension.  
NO is a product of eNOS (NOS III) in the endothelium.  For functional activity eNOS 
requires the cofactors tetrahydrobiopterin and substrates oxygen and L-argenine all of 
which can be regulated by the oxidative state.  This process is subject to strict control to 
ensure appropriate vascular tone; however, a shift towards oxidative stress in vascular 
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cells can lead to the development and progression of numerous cardiovascular diseases 
including hypertension and atherosclerosis.   
Oxidative stress is a principal feature of numerous cardiovascular diseases.  
Endothelial cells and smooth muscle cells both generate ROS.  The primary ROS in the 
vascular wall are superoxide and hydrogen peroxide though others may be involved [48, 
49].  The most potent sources of ROS in the endothelium are NADPH Oxidase (Nox), 
XO, uncoupled eNOS, and the mitochondrial electron transport chain.  The balance in the 
redox state has been shown to be shear sensitive.  Many important mediators of ROS 
generation and antioxidants are directly regulated through numerous mechanosensitive 
pathways.  The shift to an oxidative state leads to increased inflammation within the cells 
thereby providing a feedback loop for further generation of ROS.  NFκB, for example, 
can be activated by ROS and will then translocate to the cell nucleus resulting in 
increased transcription of numerous ROS sources.  This series of events will eventually 
perpetuate the various stages involved in the pathogenesis of atherosclerosis. 
Reactive Oxygen Species 
 Reactive oxygen species are molecules that have an unpaired free electron and 
contain an oxygen atom.  The main ROS is superoxide, O2.-. Superoxide is produced 
when molecular oxygen gains an additional electron from an oxidative source.  
Superoxide can act as an oxidant and extract an electron from a molecule leading to the 
formation of hydrogen peroxide or superoxide can donate an electron if the target has a 
higher electron potential.   Superoxide is an unstable free radical with a short half life and 
is membrane impermeable.  Superoxide has three primary effects in vivo.  At basal levels, 
superoxide can serve as a signaling molecule mediating numerous physiologic functions.  
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As a signaling molecule it can alter the function of target proteins including 
phosphotases, kinases, small GTPases, transcription factors, ion channels, structural 
proteins, and metabolic enzymes [49].  Additionally, superoxide can act as a precursor to 
other ROS.  In this manner superoxide can dismutate into the more stable hydrogen 
peroxide, or form the highly reactive ROS peroxynitrite.  In the production of 
peroxynitrite, superoxide reacts with NO, decreasing NO levels and providing a 
mechanism to inhibit vasodilation, eventually leading to endothelial dysfunction [50].  
Lastly, superoxide can serve as an oxidative compound reacting with the cell membrane, 
DNA, or other macromolecules.  These processes often work in a feedback manner to 
perpetuate the oxidative state.  Superoxide, for example, can react with BH4 decreasing 
the BH4 available for eNOS leading to eNOS uncoupling leading to the production of 
more superoxide [50].   
Other ROS also dictate the redox state within the cell.  Hydrogen peroxide is 
relatively stable for ROS and is membrane permeable making for a good signaling 
molecule [51].  Hydrogen peroxide can react with various targets.  For example hydrogen 
peroxide can react with thiol residues to produce sulfur oxidation which can lead to 
changes in the cell state [52].  The functional contribution of hydrogen peroxide has been 
shown in the catalase overexpression transgenic mouse model.  With increased catalase 
levels, hydrogen peroxide levels are kept low and atherosclerosis is inhibited under 
accelerated atherosclerotic conditions [Mendez and Taylor unpublished].  Hydrogen 
peroxide can also increase eNOS levels which at high levels of ROS serve to produce 
superoxide and peroxynitrite.  Peroxynitrite on the other hand, is a highly reactive non-
specific ROS.  It can oxidize and nitrate numerous biomolecules including thiols and 
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metal-containing proteins [53].  Other ROS found in vivo include the hydroxyl radical, 
hypochlorous acid, lipid peroxide, lipid peroxy- radicals, and lipid alkoxyl radicals [49].  
These additional ROS play a lesser role in the oxidative state, particularly with regards to 
the endothelium. 
Techniques for ROS Measurement 
 ROS are challenging to measure due to their relatively short half life and 
low levels.  Ideally, measurements will target an individual ROS, however current 
techniques make this very challenging.    The most common techniques include 
cytochrome C reduction, chemiluminescence-based techniques, ESR, DHE, DCF-DA, 
and amplex red [54].  Many of the commonly used assays have limitations particularly 
with specificity and stability.  It is often recommended to use multiple techniques or to 
use a scavenger to reduce the levels of the ROS of interest.  In our model, we require that 
the technique we use allows for endothelial specific measurement of ROS and can 
differentiate the heterogeneous levels of ROS in small regions of tissue.  We will discuss 
the applicability of current techniques to our requirements. 
The cytochrome c assay is an indirect technique to measure superoxide levels.  In 
this assay cytochrome c is reduced by superoxide (or other enzymes) changing its 
spectral absorption profile.  It can be used in whole tissue, but tissue is at the lower limit 
of signal detection and the assay works best in the presence of large amounts of 
superoxide.  This technique is good for measuring superoxide levels in cells that release 
large amounts of superoxide, such as neutrophils, however vessels generate much lower 
levels of superoxide that are below the limit of signal detection [54].   
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Chemiluminescence assays use probes which release a photon when in the 
presence of superoxide.  This technique usually uses lucigenin to measure superoxide in 
3mm lengths of vessel.  There are some limitations due to specificity and redox cycling in 
which superoxide can be generated by lucigenin [55].  These limitations can result in an 
overextimation of the amount of superoxide in a piece of tissue.  Additionally the 
technique requires a 3mm length of tissue and cannot distinguish regional changes in 
superoxide levels or determine endothelial specificity [54]. 
ESR uses a microwave radiation and an electromagnetic field to stimulate free 
radicals.  Due to the short half life of most ROS, spin probes are often used creating an 
adduct or a more stable free radical, each of which has a unique ESR spectrum.  This 
technique requires use with homogenized tissue, and therefore cannot distinguish the 
source of the superoxide or regional heterogeneity.  Additionally there is a large overhead 
cost for the ESR spectrometer, which can limit the adoption of this technique as a 
common practice [54]. 
DHE is commonly used to measure the redox state of tissue.  DHE can be 
visualized using fluorescence microscopy to look at the ethidium product that is formed 
upon reaction with ROS; however, there are concerns about the specificity in the 
formation of ethidium and it is believed that this is a measure of the redox state more so 
then a measure of superoxide [54].  When superoxide reacts with DHE it forms 2-
hydroxyethidium [56].  2-hydroxyethidium can be measured using HPLC, the peak from 
2-hydroxyethidium can be used to estimate intracellular superoxide levels.  The HPLC 
technique requires homogenization of the tissue during preparation.  A clear limitation of 
DHE is that it is light sensitive and can react with oxygen in solution making it a 
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relatively unstable dye.  This limitation makes DHE challenging to use for histology and 
in particular for en face mounting when the tissue must be mounted using a dissecting 
scope. 
DCF-DA is cell permeable and can be cleaved into DCFH by intracellular 
esterases.  DCFH can be oxidized by a variety of ROS but is primarily thought of as a 
measure of hydrogen peroxide since it does not react with superoxide.  The various 
components of this cycle are not very specific and highly unstable.  Additionally, the dye 
can itself generate ROS resulting in artifacts.  DCF-DA is primarily analyzed under 
fluorescence microscope, though it photobleaches very quickly [54, 57]. 
The amplex red assay relies on horsereadish peroxidase to catalyze the reduction 
of amplex red by hydrogen peroxide.  The product is the fluorophore, resorufin.  This 
assay measures extracellular hydrogen peroxide only and requires diffusion of hydrogen 
peroxide from the tissue into the surrounding buffer.  It is therefore not ideal for 
determining endothelial specificity or regional heterogeneity.   
These common techniques for measuring ROS are not ideal for analysis of 
superoxide levels from endothelial cells in vivo (or ex vivo).  We have recently worked 
with a collaborator to develop a novel superoxide sensitive dye, hydro-Cy3, which is 
significantly more stable than DHE for histological uses [58].  We will investigate the use 
of this dye to investigate endothelial specific production of superoxide. 
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Sources of Reactive Oxygen Species 
 The NADPH Oxidase family is a major source of ROS in the endothelium.  This 
family is made up of complexes that contain a catalytic, membrane bound, Nox domain.  
This Nox domain catalyzes the transfer of an electron from NADPH to oxygen.  There 
are four NADPH Oxidase isoforms that are expressed in the endothelium: Nox 1-, Nox2-, 
Nox4-, and Nox5-dependent NADPH oxidase.  Measurements of endothelial mRNA 
levels have shown that Nox 4 mRNA and Nox 2 mRNA are expressed at high levels 
while Nox 5 and Nox 1 mRNA are expressed at relatively low levels [51, 59].   NADPH 
oxidase isoform activation requires translocation and assembly of Nox subunits. The 
subunit p22 phox is a subunit for Nox 1, 2, and 4 and can serve as a docking platform for 
p47 phox, though p47 phox is not needed for Nox 4 [49, 60].  mRNA levels of Nox 
isoforms and Nox complex subunits have been shown to be upregulated by 
proatherogenic stimuli.   
Xanthine oxidase is another potent source of superoxide.   Xanthine oxidase is a 
ROS-producing form of xanthine oxidoreductase in which XO uses oxygen as an electron 
acceptor.  Xanthine oxidoreductase also exists in a non-ROS producing form, XDH [49, 
60].  The ratio between XDH and XO is determinant of the oxidative state within the cell.  
The transition from XDH to XO can occur due to stimulation by inflammatory cytokines 
as well as through oxidation of cysteine residues by ROS, particularly peroxynitrite.  This 
conversion has been shown to be stimulated by an increase in the activation of NADPH 
oxidase further perpetuating the oxidant state.   
Endothelial nitric oxide synthase can become another source for ROS when the 
two subunits become uncoupled [49, 60, 61].  Under physiologic conditions, eNOS 
30 
expression is high, resulting in the production and bioavailability of the atheroprotective 
molecule nitric oxide.  However, in the absence of BH4, eNOS becomes uncoupled and 
electrons are transferred to oxygen instead of L-argenine, resulting in the formation of 
superoxide.  As a cell shifts to an oxidative state, some eNOS remains coupled allowing 
for low levels of NO production that will further perpetuate formation of differing 
reactive oxygen species. 
The final major contributor of ROS in the endothelium is the mitochondrial 
electron transport chain [49].  The mitochondrial electron transport chain acts through 
numerous complexes, I through IV, to pass an electron along from one complex to the 
next.  The various complexes can then facilitate the transfer of the electron to oxygen 
producing superoxide depending on the electrochemical gradient.  A proton is often 
transferred out of the mitochondria to maintain the electrochemical gradient.  It is 
challenging to experimentally isolate the contribution of the mitochondrial electron 
transport chain to the production of ROS; however, it has been suggested that this may be 
a shear dependent process [62]. 
The ROS sources described thus far have focused on the production of 
superoxide, however, numerous other ROS forms exist.  Two other principal forms of 
reactive oxygen species contributing to an oxidant state in the endothelium are 
peroxynitrite and hydrogen peroxide [49, 63].  Superoxide dismutase can scavenge 
superoxide to form hydrogen peroxide which can be converted to water and oxygen by 
catalase.  Superoxide dismutase levels are increased in the presence of NO and can be 
increased by laminar flow [64].  Hydrogen peroxide can also form by spontaneous 
dismutation of oxygen or it can be generated directly by NADPH oxidases.  The highly 
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reactive superoxide can also react directly with NO to form peroxynitrite.  This balance 
between superoxide and NO is an important determinant of the redox state.  These three 
forms of ROS appear to play key roles in the development of atherosclerosis; however, 
the specific contribution of the various sources and each individual ROS are still 
unknown. 
 
Figure 2.6 – Generation of Reactive Oxygen Species - ROS sources convert oxygen to 
superoxide.  Superoxide can either be scavenged by SOD to form hydrogen peroxide or 
react with NO to form peroxynitrite.  Hydrogen peroxide can be converted to water and 
oxygen by catalase.  Image adapted with permission from [65] 
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Low Magnitude Oscillatory WSS and ROS 
It is known that atherosclerotic lesions develop in regions of low magnitude 
oscillatory WSS, but the mechanism by which this process occurs is still unknown.  ROS 
have been implicated as mediators in this process.   Cell culture studies have shown that 
Nox expression changes in response to different flow patterns.  Low magnitude 
oscillatory WSS increases expression of various NADPH oxidase subunits including Nox 
2 and Nox 4 [66].  A corresponding increase in superoxide levels was also observed and 
could be attenuated by treatment with an NADPH inhibitor, 2-DOG, which blocks the 
pentose shunt pathway for NADPH production.  Superoxide generated in response to 
oscillatory WSS has also been shown to be inhibited in cells from p47 phox-/- mice 
leading to inhibition of monocyte binding [67].  A separate study found similar, but 
slightly different results; oscillatory WSS increased expression of Nox 1 and Nox 2 but 
not Nox 4 [68].    This study showed oscillatory WSS increased monocyte adhesion 
which could be attenuated by knocking out p47phox, inhibiting BMP4, or through Nox1 
siRNA treatment.  There are some disparities between these studies, possibly due to 
differing cell types (MAECS vs BAECS), varying time courses (6 hours to 18 hours), 
differing flow patterns, or differing culture conditions.  They all suggest however that 
superoxide is generated in response to oscillatory WSS through an NADPH oxidase 
mechanism, and in particular implicate the Nox 2-dependent NADPH oxidase.  
Additionally, monocyte binding and cell adhesion molecule expression increase in 
response to oscillatory WSS also mediated by NADPH oxidase.  Indirect studies have 
shown that Nox can be activated through activation of tyrosine kinase c-Src, 
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transactivation of EGFR, and G-protein Rac-1 translocation, all of which  have been 
shown to change activity in response to low, oscillatory shear [60].   
Few studies have investigated shear dependent redox signaling in vivo, though the 
development of novel in vivo flow models is leading to increased research.  A recent 
study showed that in low oscillatory WSS model of highly accelerated atherosclerosis, 
p47 phox-/- had attenuated superoxide generation and lesion development [27].  
Additionally, the study showed increased superoxide levels in response to low oscillatory 
WSS and an attenuated response in p47 phox-/- mice.  The majority of the superoxide 
generation in this model appeared to be in the adventitia and not the endothelium, and 
therefore, the source and stimulus of the superoxide generation requires further 
investigation.  Some inferences can also be made from atherosclerosis models where 
lesions first form in the aortic sinus.  Though the flow patterns in the aortic sinus have yet 
to be characterized, it is likely that the flow is disturbed in the surrounding region.  
Studies have shown that lesion formation throughout the whole aorta is attenuated in p47 
phox-/- mice; however, when only analyzing the aortic sinus, there was no difference in 
lesion formation between the control and the p47 phox-/- mice [69].  This region of the 
aortic sinus may be involved in flow mediated lesion formation, while lesion formation in 
the whole aorta is primarily mediated by accelerated atherogenic conditions (i.e. 
atherogenic diet fed to apoE-/- mice) and not flow.  These results suggest that p47 phox 
might not be involved in flow mediated lesion formation. 
Studies have also shown that other ROS sources are regulated in response to shear 
stress potentially allowing for parallel mechanisms of ROS generation [70].  Low WSS 
has been shown to produce increased levels of xanthine oxidase in relation to xanthine 
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dehydrogenase resulting in increased superoxide generation.  Additionally antioxidant 
enzymes have been shown to be down regulated by low magnitude oscillatory WSS [71, 
72].  Low endothelial wall shear stress can decrease gene expression of superoxide 
dismutase or glutathione peroxidase [71, 73].  It is clear that these pathways are very 
complex and likely and involve numerous enzymes.  Further research is needed to 
identify the molecular mechanisms by which low oscillatory WSS mediates redox 
signaling, especially in vivo. 
Antioxidants 
 Oxidative stress has been shown to be a principal component to cardiovascular 
disease development.  It has therefore been speculated that treatment with antioxidants 
might stabilize the oxidative state and prevent cardiovascular disease.  Clinical studies 
have tested various antioxidants including ascorbate, vitamin-E, coenzyme Q10, probucol, 
iron chelators (desferrioamine), or polyphenols [49].  Many of these treatments have 
shown some beneficaial effects, though results have been inconsistent.  Further research 
is needed into the pharmacologic kinetics and molecular mechanisms by which these 
drugs act such that the dose of the antioxidant can be optimized as a treatment.  
Additionally, antioxidants treatment can be used in animal models to investigate the 
functional contribution of an ROS or ROS source to disease development; however, it is 
important to recognize the limitations and specificity of each inhibitor.   
 Selective inhibition of superoxide producing enzymes allows for investigation of 
individual pathways.  Apocynin is an antioxidant, which inhibits the formation of the 
NADPH-oxidase complex.  It is believed that apocynin inhibits the translocation of 
p47phox to the plasma membrane [74], though it is suspected that apocynin activation 
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requires MPO and hydrogen peroxide [75].  Studies have shown that treatment of 
endothelial cells with apocynin can inhibit NADPH oxidase activity and the generation of 
superoxide [76].   In vivo studies have shown that treatment with apocynin can decrease 
blood pressure and arterial superoxide levels [77, 78].  Apocynin has also been reported 
to increase ROS levels in some studies due to a suspected decrease in glutathione activity 
[79].  Additionally apocynin has been reported as a ROS scavenger [80].  Due to the 
many disparities in the literature about the function of apocynin further research is 
needed to determine the mode of action.   
 DPI is another antioxidant often used as an inhibitor of NADPH oxidase.  DPI, 
inhibits other flavoproteins as well, and therefore is not a selective inhibitor [50].  Studies 
have shown that DPI can inhibit xanthine oxidase as well as NOS [81-83] both of which 
can generate superoxide.  DPI has been shown in numerous studies to decrease 
superoxide levels [50].  Other inhibitors of Nox that are less frequently used include 
AEBSF, neopetrin, and gp91ds-tat; however reports have also questioned the specificity 
and potency of these inhibitors [84]. 
 Other antioxidants that serve to decrease superoxide levels are of the form of 
SOD.  Recombinant forms of Cu/Zn-SOD and Mn-SOD exist but have a very short half-
life.  PEG-SOD and other modified forms of SOD are also available and are significantly 
more stable than the recombinant SOD [85].  Tempol is an SOD mimetic that can 
scavenge superoxide but at high concentrations (on the order of 1 mM) can generate ROS 
[86].  Recent dose response studies have shown that a mid-level concentration (between 
100uM and 1mM) is required to attenuate Ang-II induced superoxide generation in cell 
culture [87].  In vivo studies have shown tempol to be anti-hypertensive at various doses 
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[86, 88, 89].  Interestingly, in a hypertension model, tempol treatment did not lower 
superoxide levels [89].  Further work remains to characterize the bioavailability of 
tempol and proper dose in vivo.   
 Antioxidants that target other ROS also exist.  Ebselen was commonly thought of 
as a glutathione peroxidase mimetic, however, recently ebselen has also been shown to 
use the thioredoxin system for antioxidant effects [90].  Ebselen has been shown to 
reduce hydrogen peroxide levels and peroxynitrite levels in vitro [91, 92].  In vivo models 
using ebselen treatment have shown antioxidant effects as well as protective effects from 
cardiovascular disease [93].  L-Arginine and tetrahydrobiopterin are cofactors of eNOS 
that may be thought of as antioxidants since they help increase NO production and 
prevent endothelial dysfunction [94-96].  Increased levels of these cofactors may also 
help prevent the uncoupling of eNOS which would then generate ROS.  N(omega)-nitro-
L-NAME is an inhibitor of NOS and at times used to investigate NOS as an oxidant.  
However, when L-NAME is given to apoE-/- mice, the NO mediated vascular response is 
inhibited and atherosclerotic lesion formation significantly increases [97].  Results can 
therefore be challenging to interpret. 
 Antioxidant treatment can provide useful information about redox mechanisms; 
however, care must be taken in the interpretation due to the lack of specificity of many of 
the antioxidants.  Antioxidant treatment in vivo should be complemented with the use of 
knock out mice when available.  Using these two methods in combination can help 
overcome limitations and validate results. 
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Endothelial Inflammatory State 
One of the initial events in atherogenesis is the recruitment of inflammatory cells 
into the intima of the vessel wall at regions of disturbed flow.  In these regions, 
inflammatory proteins have been shown to be upregulated, in particular cell adhesion 
molecules which mediate leukocyte rolling and migration.  VCAM-1 and ICAM-1 have 
been shown to be shear responsive both in vitro and in vivo.  Expression of inflammatory 
proteins is believed to be mediated by the activation of the transcription factor NFκB.  
Numerous studies have implicated ROS as mediators of NFκB activation and VCAM-1 
expression thereby leading to atherogenesis. 
NFκB 
NFκB is a transcription factor involved in the control of many inflammatory 
genes including VCAM-1 and ICAM-1.  It is a heterodimer composed of the p50 and p65 
subunits.  While inactive it is bound to the inhibitor I-κB in the cytoplasm.  Activation 
occurs through the phosphorylation of I-κB, which is then marked for degradation.  
NFκB then translocates to the nucleus at which point it acts as a transcription factor.  
There are many regulatory steps in this pathway: production of an inhibitor, 
phosphorylation of an inhibitor, degradation of an inhibitor, translocation of NFκB, 
phosphorylation of NF-κB, modification of NF-κB binding sites, among others.  NFκB 
has been described as the “Prototypical transcription factor subject to redox control [49].” 
Reactive oxygen species generation leads to an oxidant state that is associated 
with changes in the transcription profile of a cell.  Of particular importance are the effects 
from the transcription factor NFκB.  NFκB can be upregulated directly by an acute 
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change in shear stress and activated in regions predisposed to lesion formation [98-101].  
At low, oscillatory levels it has been shown that NFκB can increase ROS generation [98].  
ROS also appear to act in a positive feedback manner to further perpetuate the increase in 
NFκB expression and activation [102].  It has been proposed that ROS act to degrade the 
NFκB inhibitor IκB allowing for activation and translocation of NFκB to the nucleus 
[98].  This has been shown using varying anti-oxidants to inhibit NFκB translocation.  
Additionally ROS have been shown to facilitate gene transcription in the nucleus by 
NFκB.    NFκB has been shown to regulate gene transcription for numerous atherogenic 
proteins including TNF-alpha, IL-1, macrophage colony stimulating factor, VCAM-1, 
and ICAM-1, among others [98, 102-104].  As NFκB levels increase and the transcription 
factor translocates to the nucleus of the cell, there is a shift to an atherogenic transcription 
profile resulting in an increase in inflammatory protein signaling. 
Cell Adhesion Molecules 
One of the earliest identifiable atherogenic events is the expression of 
inflammatory cell adhesion molecules and subsequent monocyte adhesion.  Cell adhesion 
molecules, in particular VCAM-1 and ICAM-1, facilitate tethering and firm adhesion of 
rolling leukocytes leading to extravasation into the intima.  VCAM-1 is a member of the 
immunoglobulin superfamily that localizes to the surface of endothelial cells, allowing 
for exposure directly to the lumen of the vessel.  It binds the integrin receptor VLA-4 to 
facilitate tethering and rolling of leukocytes.  VCAM-1 expression can be upregulated by 
numerous cytokines but the promoter region of the VCAM-1 gene is known to have two 
NFκB binding sites [105].  Similar to VCAM-1, ICAM-1 is a member of the 
immunoglobulin superfamily that binds an integrin receptor, in this case LFA-1 or MAC-
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1.  ICAM-1 facilitates the firm arrest of leukocytes and the transmigration into the vessel 
wall.  Both cell adhesion molecules are constituitively expressed at low levels but can be 
upregulated by numerous stimuli [106]. 
VCAM-1 and ICAM-1 have been shown to be WSS sensitive with ROS and 
NFκB implicated as mediators [66, 68, 107].  The VCAM-1 gene in particular has two 
NFκB binding sites in its promoter region resulting in increased VCAM-1 expression in 
response to increased NFκB levels and activation [98, 99].  ICAM-1 expression on the 
other hand has been shown to be regulated by numerous inflammatory cytokines that are 
regulated by NFκB such as IL-1 and TNF-alpha.  Studies have shown that ROS 
inhibition through antioxidants profoundly attenuates inflammatory protein expression 
likely through diminished NFκB levels [98, 102, 108].  While there is general agreement 
that VCAM-1 and ICAM-1 are upregulated by low magnitude and/or oscillatory WSS, 
some in vitro studies have shown differing data [66, 68, 71, 98, 107, 109, 110].  The 
varying cell types, culture conditions, and environmental factors in vitro make an in vivo 
study essential for determining the shear induced expression of cell adhesion molecules.  
In vivo studies have correlated increased expression to areas predisposed to 
atherosclerotic lesions [20-22, 27, 111-113].  Knockout mice deficient in either VCAM-1 
or ICAM-1 show significantly attenuated lesion formation [111, 114].  Though VCAM-1 
ko is embryonic lethal, the VCAM-1 mice are domain 4-deficient (D4D) and have 
decreased VCAM-1 expression.  ICAM-1 deficiency attenuates lesion formation in an 
accelerated atherosclerosis model where lesions form in a non-flow dependent manner 
throughout the whole aorta [114].  In a model investigating flow dependent lesion 
formation in the aortic arch and aortic sinus, VCAM-1 deficiency attenuated lesion 
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formation but ICAM-1 deficiency resulted in normal lesion formation, comparable to the 
control [111].  These results suggest that although both adhesion molecules are important 
for lesion formation and are regulated by flow, VCAM-1 may play a more critical role in 
flow-dependent atherogenesis than ICAM-1.    
Background Summary 
 Atherosclerosis is a major burden on the American population.  It is a 
multifactoral inflammatory disease of the vasculature that is predisposed to localization 
in regions of disturbed flow.  Endothelial cells act as mechanotransducers to respond to 
differeing flow patterns which can lead to a healthy physiologic state or a pathologic 
state.  Cell culture studies have shown that endothelial cells exposed to disturbed flow 
have an atherogenic phenotype with increased oxidative stress and inflammation.  These 
data primarily come from cell culture studies and have provided a wealth of insight into 
the molecular mechanisms leading to lesion localization; however, there are clear 
differences between the in vitro and in vivo environments.  Mice provide an ideal in vivo 
animal model in which to investigate in vivo molecular mechanisms of 
mechanotransduction.  There are currently only a few in vivo flow models that provide 
environments of disturbed flow.  Improved in vivo models of disturbed flow along with 
the wealth of transgenic and knock out animals will allow for further investigation of 





MURINE AORTIC COARCTATION MODEL 
Specific Aim I -  Develop an acute mouse aortic coarctation model  
Introduction 
 Our first objective was to develop a simple in vivo coarctation model and 
characterize the associated hemodynamic environment.  Most flow studies currently 
utilize in vitro flow setups with simplified WSS profiles.  In vitro experiments provide 
insight into the behavior of endothelial cells; however, they lack the complex 
biochemical environment in which the endothelial cells live in vivo.  In vivo flow models 
fall into two categories: chronic or device-based.   The chronic in vivo flow models 
provide a pathologic environment, but the complex hemodynamics are difficult to model 
and chronic adaptive changes may have occurred.  Alternatively device-based models 
allow for the investigation of mechanotransduction pathways in response to acutely 
disturbed flow.  These models can potentially separate the effects of compensatory 
mechanisms from pathways activated by direct mechanical transduction.  Currently, these 
models are limited by complex procedures that do not have fully characterized 
hemodynamic environments and often do not produce low magnitude oscillatory WSS.   
Therefore, there is a lack of adequate in vivo models that can be used to analyze the 
molecular mechanisms involved in pathologic mechanotransduction.  
Our objective for aim 1 was to develop an in vivo coarctation model of controlled 
hemodynamic conditions.  The coarctation model was designed with the criteria that a 
region of low magnitude oscillatory WSS was created downstream from the stenosis and 
that there was no significant loss in blood pressure or change in strain.    Our model 
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overcomes the limitations of previous flow models by inducing a precisely defined 
coarctation in the suprarenal region of the aorta using a shape memory nitinol clip.  We 
used µCT and MRI techniques to obtain boundary conditions for a computational fluid 
dynamic model.  Using our CFD in silico model we characterized the hemodynamic 
environment associated with our in vivo coarctation model.  This in vivo model with a 
controlled mechanical environment provides a powerful tool for the analysis of shear 






C57/BL6 mice were purchased from Jackson Laboratories.  Male mice aged 11-
13 weeks were used for this study.  The animals were housed and cared for according to 
the guidelines proposed by the National Institute of Health and the experimental protocol 
was approved by the Emory University Institutional Animal Care and Use Committee. 
Clip Design - SMP Clip Manufacturing 
We used a SMP clip surgically implanted around the suprarenal aorta of twelve 
week old wild type mice (C57 Bl/6) to induce a coarctation.  The SMP was first  
polymerized into thin sheets by photopolymerization of t-butyl acrylate cross linked with 
polyethyleneglycol dimethacrylate using a photo initiator [115].  Circular clips were then 
cut out of the sheets using a CO2 laser cutter.  We manufactured clips with varying inner 
diameters and thicknesses to optimize the conditions for the coarctations.  The resolution 
limitations of the laser cutter allowed for manufacturing of clips with inner diameters as 
small as 0.3 mm and increasing diameters by 0.05mm.  We used a range of coarctations 
with different inner diameters between 0.6 mm and 1.0 mm.  As a control we used a non-
coarcted model and a non-obstructive sham model where the internal diameter of the clip 
is larger than the aorta.  These clips uniquely exhibited a shape memory effect in which 
they can recover to a preset shape due to a thermal activation (similar to figure 3.1) .   
The circular clips were heated to a deformation temperature in boiling water and 
deformed to a linear shape.  The polymer was then cooled and set in a temporary linear 
shape.  The clip could then be implanted underneath the aorta of a mouse.  Upon 
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implantation the body temperature of the mouse thermally activated the recovery of the 
clip to return to its original shape, thereby inducing a coarctation.  External heat was 
applied by warmed saline to increase the rate of recovery as necessary.  All clips were 
sterilized in 90% ethanol prior to implantation. 
Nitinol Clips  
Superelastic nitinol tubing was purchased from Memry (Menlo Park, CA – Tube-
BB-32X39.5 and Tube-BB-54.4X70.8) in various sizes.  The tubing was cut into 1 mm 
lengths using a diamond saw (Struers Accutom-2 with a Struers 805861 blade,).  Each 
1mm segment of tubing was then cut axially using an infrared laser cutter (Impressario 
Q-switched Nd:YLF - Resonetics, Nashua, NH)  producing C-shaped clips 1 mm in 
length (figure 3.1).  The clips were then heat treated to transition them from a superelastic 
state to a shape memory state in which the recovery temperature was optimized for in 
vivo conditions at 36 deg C.  Clips were heated in an oven at 450˚ C for 2.5 hours then 




Figure 3.1 – Shape Memory Properties of a Nitinol Clip -  The left panel shows the 
stages of the shape memory response of the nitinol clip.  At room temperature the clip 
can be readily deformed by an applied force and hold the temporary shape.  In the 
temporary shape the clip can be inserted underneath the aorta of the mouse.  The body 
temperature of the mouse then thermally activates the recovery of the clip and the clip 
returns to its original shape inducing a coarctation.  The right figure shows the location of 
the coarctation.  The clips were placed proximal to the celiac branch and distal to the 
diaphragm.   
Coarctation Surgery  
Male C57/Bl6 mice were anesthesized using isoflurane (oxygen was delivered 
through inhalation at a flow rate of 0.5L/min mixed with isoflurane at 3% for induction 
and 1.5% for maintenance).  All hair was removed from the surgical field by first shaving 
using clippers then applying a depilatory (Nair).  The skin was then sterilized using a 
betadine wipe to maintain an aseptic surgical area.  An incision was made along the 
midline of the skin and peritoneum of the abdomen.  The abdominal cavity was exposed 
using a self-retaining retractor (World Precision Instruments, Inc.) to push open the skin 
and peritoneum.  The intestines were displaced from the abdominal cavity and placed 
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between two sterile pledglets of gauze soaked in saline.  The abdominal aorta was then 
located using a dissecting microscope (Olympus).  Periadventitial fat was removed by 
performing a blunt dissection with micro-forceps.  The clip, either nitinol or SMP, was 
then deformed to an open state and placed underneath the aorta.  The body temperature 
from the mouse thermally activated the recovery response of the clip inducing a 
coarctation of the aorta.  The thermal recovery was assisted as needed by applying 
warmed saline locally to the clip to increase the rate of recovery.  The intestines were 
then returned to the abdominal cavity and the peritoneum and skin were sewn together 
with absorbable sutures.  Finally surgical staples were applied along the incision line to 
ensure proper healing.  The animals were then kept on heating pads during recovery and 
given buprenorphine (0.01 mg/kg intraperitoneal) as necessary. 
Magnetic Resonance Velocimetry  
Male C57/Bl6 mice were anesthesized using oxygen delivered through inhalation 
at a flow rate of 0.5L/min mixed with isolflurane at 3% for induction and 1.5% for 
maintenance.  Imaging was performed using a 4.7 Tesla Varian INOVA MRI scanner 
(Varian, Palo Alto, CA).  The suprarenal region of the aorta was located and cine images 
were acquired taking ten frames, equally spaced over the cardiac cycle [19].  Image J 
(NIH, Bethesda, MD) was then used to obtain average cross sectional velocity values.  
 
Catheter Based Pressure Measurements   
Mice were anesthetized with isoflurane as described above. A Millar pressure 
catheter (Millar Instruments SPR-671 Pressure Transducer, AD Instruments, Colorado 
Springs, CO) was inserted into the right carotid artery and right iliac artery to measure 
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blood pressure above and below the abdominal aorta [117]. Baseline blood pressure was 
measured for 10 minutes.  The abdomen was then opened and a nitinol clip was placed 
around the aorta as described earlier.  The abdomen was then closed and the blood 
pressure was allowed to equilibrate before the upstream and downstream blood pressures 
were recorded for 10 minutes.  Data were acquired and analyzed using a Powerlab system 
and Chart software (AD Instruments, Colorado Springs, CO). 
Ex-vivo Pressure Inflation  
Mice were euthanized using CO2 inhalation.  Aortas were dissected, cleaned, and 
branches were tied off with suture. Prepared aortas were cannulated in a vessel isolation 
chamber (Living Systems (LSI), Burlington, VT) that was mounted on a Nikon 
DIAPHOT 200 inverted microscope.  The aortas were stretched to the in vivo length, 
bathed with 37°C DMEM (Sigma-Aldrich, St. Louis, MO) with HEPES buffer at pH 7.4 
containing 10 µM sodium nitroprusside, and allowed to equilibrate for 30 minutes. 
Transmural pressure was ramped from 0 to 130 mmHg at 0.5 mmHg/sec using a 
peristaltic pump and pressure controller (LSI).  A video dimension analyzer (LSI) was 
used to optically measure the outer diameter of the vessel during the transmural pressure 
ramp to obtain compliance measurements. 
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µCT Imaging Specimen Preparation  
Tissues were prepared in accordance with previously described methods [20, 
118].  Animals were euthanized using CO2 inhalation.  The thoracic cavity was opened 
and the inferior vena cava was cut.  A needle was placed in the left ventricle and the 
vasculature was perfused at a pressure of 100 mmHg with 0.9% normal saline for five 
minutes followed by 10% neutral buffered formalin for five minutes.  The formalin was 
flushed from the vasculature with saline.  Microfil (Flow Tech, Carver Ma) was prepared 
per the manufacture’s guidelines and then injected into the vasculature.  Tissue was then 
decalcified in Cal-Ex II for 48 hours. 
µCT Imaging  
The abdominal aorta was imaged using a high resolution (20um isotropic voxel 
size) µCT imaging system (µCT 40 Scanco Medical, Basserdorf, Switzerland). The 
parameters were set to a voltage of 55kVp, current of 145 uA, and resolution set to 
medium.  The raw data was reconstructed into serial tomograms using a cone beam 
filtered back projection algorithm [118]. A global threshold was applied to the 
tomograms which were then exported as a 3-D reconstruction in the .stl format.  
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Figure 3.2 – Representative µCT Reconstructions - Panel A shows the morphology 
from a control aorta.  Panel B shows the morphology from an aorta with a coarctation 
from a SMP clip. 
Computational Fluid Dynamic Modeling   
Abdominal aortic morphology was imported into Geomagic software (Geomagic 
Inc., Research Triangle Park, NC).  Small branches were removed and the aortic surface 
was smoothed.  The aortic diameters were then scaled outward by an expansion factor as 
determined by in situ pressure inflation measurements.  The pathlines were created along 
the aortic surface which was then converted into NURBS format and exported as an .iges 
file.  Files were imported into GAMBIT (Ansys, Canonsburg, PA) where mesh and 
boudary layers were applied.  The files were exported as .msh and imported into 
FLUENT (Ansys).  Blunt, cross sectional averaged, inlet velocity profiles over the time 
course of a cardiac cycle were obtained from MR phase contrast velocimetry.  Outlet 
conditions were set to 80 mmHg as an approximate mean arterial pressure.  Maps of WSS 
were then generated in Fluent while velocity profiles were generated using Paraview 
(Kitware, Inc,, Clifton park, NY).    
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Statistical Analysis  
Quantitative results were analyzed with a one-way ANOVA using GraphPad 
Prism software (GraphPad Software, La Jolla, CA).  Results are shown as mean ± SEM.  




Aortic Coarctation Using SMP Clips 
 We found that the SMP clip was able to induce a coarctation of the mouse aorta.  
Figure 3.3 shows WSS maps from a control aorta and an aorta with a SMP clip induced 
coartation.  The map shows the WSS during the downstroke of systole, when flow 
separation is most likely to occur.  WSS levels in the upstream aorta had levels near 400 
dynes/cm2 for both the control and coarctation aortas.  There is some flow skewing due to 
the curvature of the spine resulting in a heterogeneous distribution of WSS in the renal 
area.  Additionally, the branch sites of the celiac artery, the superior mesenteric artery, 
and the renal arteries create areas of increased WSS at the flow divider and decreased 
WSS opposite the flow divider.  The WSS within the coarctation increases significantly 
compared to the comparable area in the control.  There is a large region of low magnitude 
WSS just downstream from the coarctation.  This WSS distribution matches the predicted 
WSS profiles from the theoretical stenosis models (figure 2.3).   
 The velocity vectors also match the predicted flow profile.  Figure 3.4 shows the 
velocity vectors in an aorta with a coarctation at various points in the cardiac cycle.  
During the upstroke of systole and during diastole flow is unidirectional through the 
region downstream from the coarctation.  During the downstroke of systole flow 
separation is observed downstream from the coarctation resulting in an oscillation in the 
flow.  This oscillation in flow is representative of the directionality of the associated 
WSS.  The WSS in this downstream region is therefore low magnitude and oscillatory 
and mimics the hemodynamic environment associated with atherogenesis.  However, it is 




Figure 3.3 – WSS map generated from a CFD model in a control mouse and a 
mouse with an SMP clip coarctation - The control mouse shows relatively high levels 
of WSS with some low magnitude regions near branch points.  The coarctation mouse 
shows a large region of low magnitude WSS downstream from the coarctation and a 




Figure 3.4 – Velocity Vectors in a Coarctation Mouse Model - During the upstroke of 
systole flow is unidirectional through the coarctation and in the downstream region.  
During the downstroke of systole flow separation occurs in the downstream region (b) 
resulting in oscillatory WSS.  
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Efficacy of the SMP Clip 
 Though the SMP clip was able to produce a region of low magnitude oscillatory 
WSS, there were issues with the reproducibility of the stenosis.  Figure 3.5 shows the 
percent stenosis using various size clips.  Even when the clip had an inner diameter of 1.0 
mm, near the size of the aorta, a significant stenosis was induced.  Furthermore, there was 
no significant difference between the stenosis induced by four different sized clips.  This 
was likely due to the large kink that is produced in the aorta due to the thickness of the 
clip.  As the clip was placed underneath the aorta, it pressed against the spine and the 
thickness displaced the aorta.  Since the thickness was 0.5 mm, about half the aortic 
diameter, a large kink was created.  The cross sectional view showed that the aorta did 
not maintain its circular morphology through the stenosis.  The aorta was flattened on the 
posterior side, where the kink was located, while the anterior side of the aorta remained 
circular.  Additionally there were significant issues in the reproducibility of the shape of 
the degree of stenosis and the cross section.  We therefore, decided to investigate using 
clips made from a different material. 
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Figure 3.5 – Comparison of Degree of Stenosis Induced by SMP Clips – We used 
µCT to obtain the morphology of aortas with coarctations produced by SMP clips.  The 
upper plot shows the percent stenosis by area that was induced by clips with varying 
inner diameters.  No significant difference in the percent of stenosis was observed 
between the groups.  There was large variability within individual groups primarily due 
to the variable shape of the aortic cross section at the site of stenosis.  The lower image 
shows a representative cross section from the middle of the coarctation.  The cross 
section had more of an oval shape than the normal round shape, likely from the kink in 
the aorta produced by the SMP clip. 
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Development of Nitinol Clip Coarctation Model  
We found that nitinol clips could be used to induce an aortic coarctation.  The 
clips uniquely exhibited a shape memory effect at body temperature (figure 3.1).  At 
room temperature the clips were deformed under an applied force and maintain a 
temporary, open state.  In this open state they were inserted underneath the aorta of the 
mouse. The body temperature of the mouse then thermally activated the recovery of the 
clips returning them to their original shape thereby inducing a coarctation.  Additionally, 
the clip had a minimal thickness, 0.01 mm, allowing for the induction of a near ideal, 
concentric, stenosis.  In performing these experiments we report a mortality rate of less 
than 10%.  The mortalities were most often the result of human error from puncturing a 
local branching artery or caused by an overdose of anesthesia. 
Characterization of the Nitinol Clip Coarctation   
The hemodynamic environment of our coarctation model is highly dependent on 
the morphology of the aorta at the coarctation, thus it is critical to establish the efficacy 
of this coarctation technique.  The induced stenosis was characterized as the difference 
between the diameter within the coarctation and the diameter proximal to the coarctation.  
We measured the proximal diameter and the stenotic diameter using two different 
techniques, ex vivo pressure inflation and µCT.  Ex vivo pressure inflation was used to 
increase the luminal pressure of excised aortas from 10 mmHg to 130 mmHg.  The 
proximal aortic diameter showed a sigmoidal compliance response ranging from 0.780 ± 
0.005 mm to 1.247 ± 0.032 mm, similar to previous reports (figure 3.6) (personal 
communication, Dr. Kathryn Rafferty).    We could not make direct measurements of the 
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aortic wall within the coarctation since we were unable to image through the nitinol. 
Therefore, measurements of the external diameter of the clip were obtained and the 
thickness of the clip subtracted to obtain the approximate diameter of the aorta within the 
coarctation.  These measurements showed an aortic diameter of 0.748 ± 0.003 mm, with 
no significant change over the pressure cycle.  From these measurements we calculate 
that the degree of stenosis (by diameter) induced by the clip, ranged from  29.4 ± 3.1 % at 
60 mmHg to 38.4 ± 1.9 % at 100 mmHg  These ex vivo results demonstrate the efficacy 
of the coarctation under physiologic blood pressure. 
µCT measurements were used to validate the ex vivo coarctation efficacy 
measurements.  The results show a proximal diameter of 0.80 ± 0.04 mm, and a diameter 
within the coarctation of 0.69 ± 0.02 mm.  The upstream measurements as determined by 
µCT correspond to a pressure of approximately 20 mmHg as measured by ex vivo 
inflation suggesting a fixation artifact in the µCT preparation technique.  The difference 
in the coarctation diameter between the two techniques appears to be attributable to the 
vessel wall thickness which is included in the inflation measurements but not the µCT 
measurements.  Both techniques demonstrate the efficacy of the coarctation technique 





Figure 3.6 – Fixation Effects on the Aortic Pressure Diameter Curve - Aortas were 
inflated by increasing the luminal pressure.   The diameter from the upstream region of 
the aorta was recorded.  Aortas were then fixed with formalin at 80 mmHg for 5 minutes 
and the recordings were repeated.  There was a trend for a slight decrease in compliance, 
yet there was still a significant diameter change over the pressure ramp.   This shows that 
even with pressure fixation the mouse aorta remained compliant and did not fix the 





Figure 3.7 – Coarctation Efficacy – Measurements were taken to show the 
reproducibility of the degree of stenosis induced by the coarctation surgery.  In situ 
pressure inflation (left) shows the diameter of the aorta as the luminal pressure is 
increased from 10 mmHg to 100 mmHg.  The red line shows the diameter of the aorta 
upstream from the coarctation while the purple line shows the measurements of the 
outside diameter from the nitinol clip.  The outside diameter measurements are indicative 
of the aortic diameter within in the clip and the thickness of the clip.  The black lines 
show the aortic diameter measurements obtained from µCT as reference.  The right figure 
shows diameter measurements from ex vivo µCT of aortas pressure fixed at 100mmHg.  
The measurements were taken upstream from the coarctation and at the coarctation. 
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Boundary Acquisition  
Measurements of the thoracic aortic diameter yielded disparities between values 
determined by µCT and by pressure inflation (figure 3.7).  This was likely due to the 
fixation artifact characterized in figure 3.6.  To correct for this artifact, we performed an 
in silico diameter expansion based on in situ pressure inflation measurements.  The 
expansion factor for the regions upstream and downstream from the coarctation was 
derived from the upstream ex vivo inflation measurements while the expansion factor for 
the coarcted region was derived from the inflation measurements at the clip.  An 
upstream expansion factor of 30% correlated to a blood pressure of approximately 60 
mmHg.  Additionally we used an expansion factor of 10% and 20% to look at the 
sensitivity of the CFD model to this in silico expansion.  The resultant morphology was 
then used as the boundary conditions for the morphologic input into the CFD model.  A 
representative image of the resultant morphology is shown in figure 3.8.   
The inlet aortic velocity was obtained from in vivo MR phase contrast 
velocimetry.  The cross sectional velocity was averaged to obtain a blunt, time dependent, 
velocity at ten incremental time points throughout the cardiac cycle.  Measurements were 
obtained in the upstream (suprarenal) and downstream (infrarenal) regions of control 





Figure 3.8 – Boundary Conditions and Expansion Factor - Boundary conditions were 
obtained from µCT imaging. The figure on the left shows representative raw data from a 
reconstructed aorta.  The central figure shows the aorta after in silico processing with 
Geomagic software.  The two figures on the right show the in silico expansion of the 




Figure 3.9 – Aortic Flow Profiles - Flow profiles in the suprarenal and infrarenal aorta 
of control C57 Bl/6 mice.  These profiles were generated using MR phase contrast.  
There was a significant decrease in flow in the infrarenal aorta as a large portion of the 
mouse flow is diverted to the kidneys and the gut and little to the legs.  These results are 
consistent with previous findings [19].  These flow profiles were used to obtain velocity 
profiles for the input and output boundary conditions for the CFD model. 
Aortic Blood Pressure 
Catheter-based blood pressure measurements proximal and distal to the 
coarctation region were obtained.  During the course of the insertion of the catheter into 
the femoral artery, there was a significant drop in arterial pressure, approximately 40 
mmHg.    Pressure stabilized around 50 mmHg and maintained good waveforms.  
Pressure measurements obtained prior to the coarctation surgery showed a mean arterial 
pressure differential of 3.6 ± 10.3 mmHg  while post-coarctation measurements show a 
mean arterial pressure differential of 2.1 ± 7.7 mmHg, thus showing minimal change in 
pressure differential.  
Due to the significant drop in systemic blood pressure, we also modeled the 
pressure drop across the coarctation using CFD.  The physiologic pressure drop across 
the renal arteries for a control (non-coarctation) aorta was found to be approximately 7.5 
mmHg during systole and about 1 mmHg during diastole.  The pressure drop across the 
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coarctation, on the other hand, was found to be approximately 13 mmHg during systole 
and 1 mmHg during diastole.  The pressure loss produced by the stenosis during systole 
can be estimated to be approximately 6.5 mmHg.  From our previous ex vivo inflation 
measurements of aortic compliance (figure 3.7 ), we predict that a pressure loss of 6.5 
mmHg would produce a change of less than 0.05 mm to the aortic diameter and therefore 
would have a small effect on the strain at physiologic blood pressures.  This effect is less 
than the natural variability in diameter and blood pressure between mice. 
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Figure 3.10 – Blood Pressure Measurements – The upper panel shows the blood 
pressure during systole before and after coarctation.  No significant pressure drop was 




Figure 3.11 – Pressure Drop Across the Renal Arteries in a Control Mouse – The 
computational fluid dynamic model was used to model the pressure drop in a control 
mouse.  During systole the pressure drop across the coarctation was approximately 1000 
Pascals (~7.5 mmHg) while the pressure drop during diastole was approximately 100 




Figure 3.12 – Pressure Drop Across the Coarctation – The computational fluid 
dynamic model was used to model the pressure drop across the coarctation.  During 
systole the pressure drop across the coarctation was approximately 1700 Pascals (~13 
mmHg) while the pressure drop during diastole was approximately 100 Pascals (~1 
mmHg).  
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Computational Fluid Dynamics   
 
The morphology and velocity profiles obtained as described earlier were used as 
boundary conditions to generate a computational fluid dynamic model using FLUENT 
software.  WSS maps and cross sectional velocity vectors were generated using a CFD 
model for control, non-coarctation aortas and coarctation aortas (Figures 3.13-3.21).  
Figures are presented from the early upstroke of systole, peak systole, the downstroke of 
systole, and during diastole.  The control aorta shows unidirectional velocity through the 
aorta at all four time points.  The WSS is relatively low during the early upstroke of 
systole and during diastole.  During peak systole and the downstroke of systole the 
control aorta shows high WSS throughout the aorta with a further elevated WSS region 
on the posterior side produced by velocity skewing as well as at the flow divider of 
branching vessels.  Mean WSS in the control is relatively homogenous between 10 
pascals (100 dynes/cm2) and 15 pascals (150 dynes/cm2).   
The hemodynamic environment is significantly altered in the coarctation aorta.  
During early systole and diastole, flow is unidirectional and there is a slight increase in 
WSS in the throat of the stenosis.  During peak systole, there is a significant increase in 
WSS in the throat and hotspots of high WSS on the posterior side of the aorta and at the 
flow divider of branching vessels.  Flow is mostly unidirectional, however, flow 
separation may occur in a small region immediately downstream from the coarctation on 
the anterior side of the aorta.  This region of flow separation becomes very large during 
the downstroke of systole, still on the anterior side of the aorta.  Additionally a large 
region of low magnitude WSS can be observed on the anterior side of the aorta, 
downstream from the coarctation.  This clearly creates a region of low magnitude 
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oscillatory WSS downstream from the coarctation on the anterior side of the aorta.  The 
mean WSS map for the coarctation aorta shows low mean WSS in this downstream, 
anterior, region.       These models showed unidirectional and relatively high magnitude 
WSS in the upstream, thoracic, region of control and coarcted mice.  The spatial 
heterogeneity of the WSS was relatively minimal with some skewing towards the 
posterior side due to the curvature of the spine.  Downstream from the site of the aortic 
coarctation the model showed low magnitude oscillatory WSS on the anterior side of the 
aorta, while the control animals showed unidirectional flow with high magnitude WSS.   
From these results we identified three regions of interest: the thoracic aorta, the 
low magnitude oscillatory WSS region in the abdominal aorta of mice from the 
coarctation group, and the comparable abdominal region near the celiac branch in control 
animals.  We included the aortic arch as an additional region of interest based on previous 
studies showing chronic induction of low oscillatory WSS in this region [20].  This 
animal model can therefore compare regions of high magnitude unidirectional WSS with 
regions of both acutely and chronically disturbed flow producing low magnitude 




Figure 3.13– Velocity Vectors During Early Systole - Velocity vectors (m/s) from 
control and coarctation aortas during early systole.  Flow is unidirectional throughout the 
aorta in both control and coarctation aortas. 
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Figure 3.14 – WSS Map During Early Systole - WSS map (Pascals) from control and 
coarctation aortas during the initiation of systole. WSS is relatively low in both control 





Figure 3.15 – Velocity Vectors During Peak Systole - Velocity vectors (m/s) from 
control and coarctation aortas during peak systole.  Flow is high and unidirectional in the 
control aorta.  The velocity in the throat of the coarctation increases significantly while 





Figure 3.16 - WSS Map During Peak Systole – WSS map (pascals) from control and 
coarctation aortas during peak systole –  WSS is relatively high in posth the control and 
coarctation aortas with hotspots at the flow divider of branching vessels.  Additionally 




Figure 3.17 – Velocity Vectors During the Downstroke of Systole - Velocity vectors 
(m/s) from control and coarctation aortas during the downstroke of systole.  Flow is 
unidirectional in the control aorta.  There is a large region of flow separation downstream 
from the coarctation on the anterior side of the aorta. 
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Figure 3.18 – WSS Map During the Downstroke of Systole - WSS maps (pascals) 
from control and coarctation aortas during the downstroke of systole.  WSS is still 
relatively high in the control aorta.  There is a significant decrease in WSS in the region 
downstream from the coarctation on the anterior side of the aorta. 
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Figure 3.19 – Velocity Vectors During Diastole - Velocity vectors (m/s) from control 





Figure 3.20 – WSS Map During Diastole - WSS (pascals) from control and coarctation 
aortas during diastole.  WSS is relatively low in both models. 
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Figure 3.21 - Mean WSS Maps - Representative mean WSS (Pascals) maps.  Maps were 
generated from CFD models of a control mouse aorta (upper image) and a coarctation 
mouse aortic (lower image).  Mean WSS is significantly reduced downstream from the 
coarctation on the anterior side of the aorta. 
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Sensitivity Analysis 
We performed a sensitivity analysis to investigate the sensitivity of flow reversal 
and WSS magnitude to the in silico expansion.  Figure shows an aorta with no expansion 
factor, a 10% expansion factor, a 20% expansion factor and a 30% expansion factor.  
From our ex vivo inflation measurements, we determined that the 10% expansion factor 
(upstream diameter ~ 0.90mm) corresponds to a pressure of 30 mmHg, a 20% expansion 
factor (upstream diameter ~ 0.96 mm) corresponds to a pressure of 40mmHg, and a 30% 
expansion factor (upstream diameter ~ 1.03 mm) corresponds to a pressure of 60 mmHg.  
With either a 10% expansion factor or no expansion factor flow reversal was not 
observed in the downstream region and WSS was not significantly decreased.  Using a 
20% or 30% expansion factor, a region of low magnitude WSS along with flow reversal 
can be observed in the downstream region.  The use of a 30% expansion factor correlates 
to a blood pressure of 60 mmHg, which is expected to be a conservative estimate since 




Figure 3.22 – Sensitivity Analysis of the Expansion Factor -  Panels A, C, E, and F 
show representative WSS maps (Pascals) while panels B, D, F, and H show velocity 
vectors all from the downstroke of systole.  Panels A and B show the aorta with no 
expansion factor.  WSS is relatively low and flow is unidirectional.  Panels C and D show 
an aorta after the application of a 10% expansion factor, which correlates to an in vivo 
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pressure of 30 mmHg.  At a 10 % expansion factor, flow is unidirectional and WSS is 
starting to show lower relative levels immediately downstream.  Panels E and F show an 
aorta that has had a 20% expansion factor applied to it, correlating to an in vivo pressure 
of approximately 40 mmHg.  There is a large region of low magnitude WSS and flow 
reversal can be observed on the anterior side.  The panels G and H show an aorta with a 
30 % expansion factor correlating to a pressure of 60 mmHg.  These panels show a large 
region of low magnitude WSS and flow reversal. 
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Discussion 
Our objective for this aim was to develop a novel mouse model of acutely 
disturbed flow.  We present two different methods to induce an aortic coarctation.  The 
first method uses a shape memory polymer clip.  Using the SMP clip we were able to 
create an environment of low magnitude oscillatory WSS.  However, this technique 
produced a large kink in the aorta due to the thickness of the clip.  We therefore, 
progressed to a model using a nitinol clip.  The nitinol clip is significantly thinner than 
the polymer clip and did not produce the large kink observed with the SMP clip.  In 
addition, the material properties of the clip were such that there was no significant effect 
of pressure changes on a physiological range on the diameter of the clip.   We thoroughly 
characterized the hemodynamic environment associated with the coarctation induced by 
the nitinol clip.  Using a combination of techniques, in situ µCT and ex vivo pressure 
inflation, we showed that we can effectively constrict the aortic diameter at the clip with 
minimal variability.    We further showed that this constriction produced a minor stenosis 
with no significant pressure loss.  The CFD model showed that the coarctation produced 
low magnitude oscillatory WSS in the distal region.   
Our main conclusion for this aim is that the nitinol clip coarctation model 
uniquely creates a hemodynamic environment of low magnitude oscillatory WSS without 
a significant effect on blood pressure.   
The initial method using the SMP clip produced a unique hemodynamic 
environment that created a region of low magnitude oscillatory WSS.  However, we had 
problems with consistency of the morphology through the coarctation and the degree of 
stenosis.  The morphology was non-uniform creating an elliptical shape with a flat 
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posterior side and a circular anterior side.  The aorta was non-concentric and was shifted 
towards the anterior aspect of the body.  These morphological features were the product 
of the thickness of the clip.  The clip was 0.5 mm thick due to manufacturing limitations 
as a result of the resolution of the laser cutter.  When the clip was placed underneath the 
aorta the clip pressed against the spine and shifted the coarctation away from the normal 
aortic pathline creating a kink in the aorta.  The result of this kink was that even the 
control, non-constricting, clip still created the same degree of stenosis as the constricting 
clip.  We therefore would not have been able to have an appropriate control to test the 
non-specific effects of the material and isolate that from any hemodynamic effects.  We 
then investigated the use of a shape memory alloy, to see if we could improve the 
morphological features associated with our coarctation model. 
The nitinol clip model produced a significantly improved and idealized stenosis.  
We used uCT and ex vivo pressure inflation to demonstrate the efficacy of the nitnol clip.  
The pressure inflation showed that we were able to induce an ideal stenosis under ex vivo 
conditions without interference from surrounding tissue.  An unintended observation 
from this experiment was that we noticed that our fixation technique did not fix the tissue 
to the morphology associated with the fixation pressure.  After fixation for 5 minutes at 
100 mmHg the aorta remained largely compliant and did not fix to the physiologic 
morphology at 100 mmHg.  We determined that when we removed the fixed tissue from 
pressure, the tissue returned to a diameter comparable to the diameter of unfixed tissue at 
30 mmHg.  When pressure was reapplied to the tissue, the diameter increased in a 
sigmoidal manner very similar to the unfixed tissue.  We then fixed the tissue for an 
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additional 45 minutes under pressure and again ran the compliance test.  Again, the fixed 
tissue remained compliant. 
We were very surprised to find that fixation under pressure did not maintain the 
morphology when pressure was released.  We speculate that this is likely due to the 
thickness of the tissue and the composition of the tissue.  The vessel wall of the mouse is 
very thin in comparison to a human tissue.  Additionally, the composition of the mouse 
vessel makes for a significantly more compliant vessel.  There is likely much less ECM 
to be fixed in the mouse vessel and the ECM that is in the vessel wall is composed of 
more elastin in comparison to collagen.  The fixative might therefore have less ECM 
available to cross link.  This is a very interesting observation and could be a point for 
further research.  With respect to this project, though, it is important to compensate for 
this lack of fixation when acquiring boundary conditions for CFD. 
The µCT measurements demonstrated that the coarctation produced an idealized, 
concentric, stenosis.  The cross sectional morphology showed that the aorta was circular 
upstream of the coarctation, in the middle of the coarctation, and downstream from the 
coarctation.  There was only a slight measureable stenosis, however, this was likely due 
to the fixation artifact described above.  Using the compliance measurements upstream 
from the coarctation, at the coarctation, and downstream from the coarctation we were 
able to determine an expansion factor.  We applied these expansion factors in silico to the 
aortic diameter of the µCT reconstruction.  When the expansion factor was applied to 
expand the tissue to an aortic diameter comparable to the diameter during diastole, about 
60 mmHg, a significant stenosis can be observed.  We used the in silico expanded aorta 
for the CFD modeling. 
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The CFD model showed results as predicted by the idealized stenosis model.  
Flow was unidirectional during the upstroke of systole, flow separation occurred during 
the downstroke of systole, and then was again unidirectional during diastole.  WSS was 
high upstream from the coarctation, increased further in the stenotic region, then 
decreased significantly downstream from the coarctation.  Additionally we showed that 
there was no significant pressure loss produced by the coarctation.  These results 
demonstrate a model with significant advantages over current in vivo murine models of 
WSS. 
The comparable murine flow models are the carotid coarctation reported by 
Cheng et al. and the carotid partial ligation reported by Nam et al. [25, 27].  Our model 
produces a unique model of low oscillatory WSS with minimal disturbances to pressure 
and therefore strain.  The carotid coarctation model reports a region of low magnitude 
unidirectional WSS and a region of high magnitude oscillatory WSS [25].  Furthermore, 
this model does not characterize any alterations to pressure and/or strain.  The partial 
ligation model reports low magnitude oscillatory WSS, but does not characterize pressure 
and/or strain.  The low flow in this model likely produces a moderate change in strain 
which could modulate the biological response.  These distinct differences in the 
mechanical environments of the three models and the limitations of each model provide 
unique in vivo models to investigate different biological responses. 
Though this model makes improvements over current in vivo WSS models, there 
are still limitations.  One limitation is that the aortic morphology near the clip can not be 
directly imaged in vivo.  In vivo intravascular µCT is very challenging in mice, 
particularly when imaging the aorta, because it is difficult to obtain significant contrast 
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between the aorta and the spine due to the high density of the bone and low radiodensity 
of the vasculature [120].  MR measurements on the other hand have high errors due to 
temporal acceleration and irregular flow through the stenosis and downstream region as 
well as signal interference around the clip [121, 122].   
We used a combination of µCT and ex vivo inflation to obtain and validate the 
morphologic boundary conditions.  Our validation requires application of an expansion 
factor in silico to best approximate the in vivo morphology.  The expansion was based on 
ex vivo pressure inflation measurements.  We performed a sensitivity analysis to 
determine the sensitivity of our model to the in silico expansion.  We determined that an 
expansion correlating to a blood pressure of 40 mmHg or greater (20% expansion factor) 
produced low magnitude oscillatory WSS while an expansion factor correlating to a 
blood pressure of 30 mmHg or less (10% expansion factor) did not produce low 
magnitude oscillatory WSS.  We conclude that the sensitivity of the model to the 
expansion factor does not effect the observation of low magnitude oscillatory WSS even 
for a conservative estimate of blood pressure at 60 mmHg. 
Another limitation is the assumption that the change in WSS is the primary 
stimulus of any response.  The coarctation creates an altered strain on the nearby aortic 
wall.  These could contribute to any response, and since we can not feasibly remove this 
variability from the model, we must make the assumption that the primary stimulus to the 
endothelium is the change in WSS.  The model is also limited in molecular analysis 
techniques due to the small region of interest.  This model is ideal for use with 
quantitative staining methods utilizing quantum dots since other techniques would likely 
require the pooling of mice [123]. 
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We conclude that this study presents a novel model of acutely disturbed flow.  
The model utilizes the shape memory response of a nitinol clip to induce an aortic 
coarctation with high reproducibility.  We showed low magnitude oscillatory WSS in the 
region distal to the coarctation.  This model can be used in future studies without the need 
for further validation of the flow environment and will significantly increase the 
accessibility of in vivo experiments addressing mechanical transduction.  This model 
provides a number of advantages over existing in vivo  mouse models of disturbed flow 
including: ease of use, high reproducibility, low mortality rate, an acute time course, and 
a fully defined hemodynamic environment exhibiting low magnitude oscillatory WSS.  
With many mechanosensitive pathways already identified in vitro, it is important to 
analyze the in vivo contribution of these various mechanisms to atherogenesis.  Taking 
advantage of the wealth of transgenics and knockout mice in combination with this flow 
model could provide significant insight into the mechanisms involved in 





ATHEROGENIC MARKERS IN A MURINE AORTIC 
COARCTATION MODEL 
Identify the expression of inflammatory markers in the mouse coarctation model 
Introduction 
 Our objective for aim 2 was to compare inflammatory marker signaling in 
response to both acute and chronic, low magnitude oscillatory WSS.  Inflammatory cell 
adhesion molecules are the earliest identifiable markers associated with atherosclerosis.  
Expression of these molecules has been associated with disturbed flow over time courses 
usually ranging from 6 hours to 72 hours [107, 124].  Even within these highly controlled 
environments there is a notable change in cell adhesion molecule expression at various 
points in the time course.  In vivo studies have correlated increased inflammatory protein 
expression to regions predisposed to atherosclerosis development.  In murine models, this 
has specifically been shown in the inner curvature of the aortic arch and opposite the flow 
divider at the brachiocephalic branch [20].  These chronically disturbed flow regions are 
believed to be atherosusceptible; however, the atherosusceptible endothelial phenotype 
appears to have increased oxidative stress and inflammation, yet is able to reach a stable 
equilibrium that does not progress to lesion formation without an additional stimulus 
[125, 126].  This stimulus can include knocking out the apoE gene, feeding a high fat diet 
or treatment with Ang II among others [119, 125].  Compensatory mechanisms are 
suspected to be activated in these chronically disturbed flow regions resulting in a stable 
yet atherosuscpetible phenotype.  This phenotype may well be different than the 
inflammatory phenotype observed in vitro where the time course is 72 hours or less. 
Our objective for specific aim 2 was to quantitatively measure the acute and 
chronic response of atherogenic markers in regions of low magnitude oscillatory WSS.  
88 
We hypothesized that the acute model would produce an endothelial phenotype that 
experiences increased oxidative stress and inflammation.  Additionally, we hypothesized 
that there would be distinct differences between the acute and chronic models, such that 
there would be an increases in NFκB and superoxide that would be present in the acute 
model, but not in the chronic model.  We quantitatively measured expression of VCAM-
1, ICAM-1, NFκB, and superoxide, using quantum dot nanoparticles with 
immunohistochemistry techniques as well as the novel superoxide sensitive dye, hydro-
Cy3 [58].  Figure 4.1 shows the proposed pathway which we investigated.  Additionally 
we were able to compare differences between the acute and chronic atherogenic response 
by analyzing the acute response downstream from the coarctation and the chronic 




Figure 4.1 - Proposed Mechanisms of Redox Signaling – Proposed mechanisms of 
redox signaling in response to low magnitude oscillatory WSS.  Each animal can be used 
as a chronic (aortic arch) and acute (aortic coarctation) model of low magnitude 
oscillatory WSS.  We propose that these models of low magnitude oscillatory WSS will 
induce activation and increased expression of NFκB, superoxide generation, and 
increased expression of VCAM-1 and ICAM-1.  We will directly measure the markers in 




C57/BL6 and apoE-/- mice were purchased from Jackson Laboratories.  Male mice 
aged 11-13 weeks were used for this study.  The animals were housed and cared for 
according to the guidelines proposed by the National Institute of Health and approved by 
the Emory University Institutional Animal Care and Use Committee. 
Coarctation Surgery  
Coarctation surgery was performed with SMP clips and nitinol clips as described 
in specific aim I. 
Immunohistochemistry  
Tissues were prepared in accordance with previously described methods [123].  
Animals were euthanized using CO2 inhalation.  The thoracic cavity was opened and the 
inferior vena cava was cut.  A needle was placed in the left ventricle and the vasculature 
was perfused at a pressure of 100 mmHg with 0.9% normal saline for five minutes 
followed by 10% neutral buffered formalin for five minutes and then rinsed again with 
saline.  Aortas were excised then washed in PBS before being permeabilized in 0.2% 
Triton X-100 (Sigma Aldrich).  Aortas were then washed overnight in a humid chamber 
at 4 degrees C with the primary antibody.  For VCAM-1 staining anti-VCAM1 antibody 
(BD Pharminogen) was diluted at 1:100 in blocking buffer (PBS, 2% BSA, 5% goat 
serum).  For ICAM-1 staining anti-ICAM-1 antibody (Southern Biotech) was diluted at 
1:100 in blocking buffer.  For NFκB staining anti-p65 antibody (eBioscience) was diluted 
at 1:250 in blocking buffer.   The following morning aortas were rinsed with PBS then 
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washed with secondary antibodies conjugated to 655 quantum dots (Invitrogen) at a 
dilution of 1:100 in blocking buffer (PBS, 2% BSA).  Aortas were then mounted en face 
on glass slides using Vectashield with DAPI (Vector Labs). 
Hydro-Cy3 Staining 
Animals were euthanized using CO2 inhalation.  The thoracic cavity was opened and the 
inferior vena cava was cut.  A needle was placed in the left ventricle and the vasculature 
was perfused at a pressure of 100 mmHg with 0.9% normal saline for five minutes.  The 
perfusion was continued with a hydro-Cy3 dilution (stock solution - 2 mg hydro-Cy3 
dissolved in 2 ml methanol, working solution – 500 µL stock solution in 100 ml 0.9% 
normal saline – final concentration 2.5 µM) for five minutes.  This was followed by 
pressure perfusion with 10% neutral buffered formalin for five minutes and then a rinse 
with normal saline.  Aortas were excised and washed in phosphate buffered saline (PBS).  
Samples were then mounted en face on glass slides using Vectashield with DAPI (Vector 
Labs).  
Microscopy and Quantification of Fluorescence Intensity  
Procedures were described previously [123].  En face images were collected using 
a Zeiss LSM 510 META single-photon microscope with a 63x (Plan-Neofluor, NA 1.3) 
oil immersion objective connected to an inverted Zeiss Axiovert 100 microscope.  
Separation of the emission signals was performed using the META detector with a 40 nm 
window for samples stained with quantum dots and a long pass filter for samples stained 
with the hydro-Cy3.  Region of interest was determined using an external registration 
with a notched slide.  Measurements were made prior to the en face mounting using the 
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dissecting microscope with the attached digital camera (Q Capture, Micropublisher 3.3) 
to determine the distance from the proximal end of the aorta to the region downstream 
from the clip (approximately 1mm, the length of the clip).  Using the confocal 
microscope, the stage location was registered at to the proximal end of the aorta.  The 
slide was switched to a notched slide and the stage was moved the distance determined 
by the dissecting scope measurements.  The slide with the en face mounted aorta was 
then returned to the stage.  Three replicate images from each region of interest were 
obtained.    A series of images, a z-stack, was taken through the intimal layer at each 
location.  Each series of images was then projected into a single image by using a 
maximum intensity projection algorithm that was built into the ZEN software.  The 
resultant projected image gives a single image representation of the endothelium which 
can then be quantified.  The mean fluorescence intensity was quantified from each 
projected image using the frequency histogram function of the ZEN examiner software. 
Epiflourescence images were obtained to produce low magnification regional 
expression profiles.  These images were obtained using an upright Zeiss microscope that 
excites the Qdots at 405 nm and detects their emission at 655 nm using a long pass filter.  
Epifluorescent images were obtained using intact aortas or en face mounted aortas.  The 




Figure 4.2 – Projection of a Confocal Z-stack – Panel A shows a single slice through 
the center of the intima.  The slice is out of plane from much of the endothelial cells and 
does not give an accurate image of the mean fluorescent intensity of the quantum dot 
staining at this location.  Panel B shows the projected image.  All nuclei are in plane and 
the mean fluorescent intensity of the quantum dots can be accurately measured.  Panel C 
shows an isometric view of the series of slices through the endothelium.  
Oil Red O   
apoE-/- mice on a normal chow diet were used for this portion of the study.  Three 
experimental groups were used: control mice with no coarctation, mice with a sham, non-
constricting clip, and mice with a coartation inducing clip.  Mice were euthanized 2 
months after the coarctation surgery and the vasculature was pressure perfused with 
saline followed by formalin.  The aortas were excised and mounted in a black wax based 
dish and preserved in formalin.  0.7g oil red o was dissolved in100 ml propylene glycol 
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and heated to 100 deg C.  The solution was then filtered through a #2 Whatman filter on 
top of a medium porosity fritted glass filter.  Aortas were then rinsed with water to 
remove formalin followed by a 15 min wash with the oil red o solution.  The aortas were 
then destained using 70% ethanol for 5 min then finally washed again with water.  The 
aortas were then imaged using a digital camera (Q Capture, Micropublisher 3.3) attached 
to a dissecting microscope (Olympus SZ61).  Oil Red O stain was then quantified using 
Image J. 
Statistical Analysis   
Quantitative results were analyzed with a one-way ANOVA using GraphPad 
Prism software (GraphPad Software, La Jolla, CA).  Results are shown as mean ± SEM.  
A p-value of <0.05 was considered statistically significant. 
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Results  
Aortic VCAM-1 Expression from a Shape Memory Polymer Clip Coarctation 
 We used an SMP clip to induce a coarctation of the aorta producing low 
magnitude oscillatory WSS downstream from the stenosis.  VCAM-1 expression was 
quantitatively measured using quatum dots for en face immunohistochemmistry.  The 
staining showed relatively low levels of VCAM-1 expression throughout the aorta in the 
control, non-coarctation, mice.  VCAM-1 expression was similarly low in the upstream 
region of a mouse with an aortic coarctation.  Downstream from the coarctation VCAM-1 
expression increased significantly.  Figure 4.3 shows representative confocal images from 
various locations in the aorta, while figure 4.4 shows regional VCAM-1 expression from 
epifluorescent images.  There is some increase in VCAM-1 expression in the coarctation 
region and even just upstream from the coarctation as observed in the epifluorescent 
images.  Though we were able to observe the expected biological response by observing 
VCAM-1 expression in the downstream region, aim I showed that the SMP produced 
variable morphology and likely an inconsistent hemodynamic environment. 





Figure 4.3 – VCAM-1 Expression Coarctation Aorta with a SMP Clip - A WSS map 
from a control animal is presented in the left panel.  Images a and b are representative 
confocal images of VCAM-1 staining in the upstream (a) and downstream (b) regions 
from control mice.  The right panel shows a WSS map from a mouse with a coarctation.  
Figures c, d, e, and f are representative confocal images of VCAM-1 staining from the 




Figure 4.4 – Epifluorescence Images of VCAM-1 Expression a Coarctation Aorta 
with a SMP Clip - The top panel shows an intact aorta.  The bottom shows an aorta 
which has been mounted en face (the signal is clearer when mounted en face).  VCAM-1 
expression is increased in the region downstream from the coarctation, though there is 
some increase in expression within the coarctation.  The clip location is approximate. 
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Nitinol Clip Coarctation 
Aim I showed that using a nitinol clip instead of an SMP clip to produce an aortic 
coarctation resulted in a more ideal and reproducible coarctation.  We sought to 
characterize the inflammatory marker response using a nitinol induced coarctation in 
comparison to the SMP induced coarctation.  Similar to the SMP induced coarctation, the 
nitinol induced coarctation showed a significant increase in expression of specific 
atherogenic markers in the region downstream from the coarctation.  Figure 4.5 shows 
low VCAM-1 expression and superoxide expression in the upstream region and an 
increase in both markers in the downstream region.   
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Figure 4.5 – VCAM-1 and Superoxide Expression in an Aorta with a Nitinol clip 
Induced Coarctation - The upper panel shows a representative WSS Map during systole 
from an aorta with a coartation (A).  There is low magnitude oscillatory WSS in the 
downstream region and physiologic unidirectional WSS in the upstream region.  The 
lower images show representative confocal images (63x) from en face mounted aortas 
stained for either VCAM-1 (B and C) or superoxide (D and E).  The images on the left (B 
and D) were taken from the upstream region while the images on the right (C and E) were 
taken from the downstream region.   
 
 
We compared VCAM-1 expression in the downstream region from control 
animals, SMP coarctation animals and nitinol coarctation animals.  A significant increase 
in VCAM-1 expression was observed downstream from the SMP clip and the nitinol clip 
with a slight attenuation of the response from animals with a nitinol clip.  Though both 
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clips produced an increase in VCAM-1 expression correlating to low magnitude 
oscillatory WSS, the nitinol clip produced a more desirable hemodynamic environment.  
Our study therefore proceeded with nitinol clips only to further investigate the molecular 
mechanisms involved in mechanotransduction of low magnitude oscillatory WSS.  
 
 
Figure 4.6 – Comparison of VCAM-1 expression using SMP clips and Nitinol Clips - 
VCAM-1 expression increases in the downstream region from coarctations induced by 
either nitinol clips or SMP clips.  n=5 *=p<0.05 
 
Cellular Adhesion Molecule Expression  
 Cellular adhesion molecules are inflammatory proteins that mediate the migration 
of leukocytes into the vessel wall and are an early marker of atherosclerosis.  We used 
quantum dot based immunohistochemistry to quantify the expression of two cellular 
adhesion molecules, VCAM-1 and ICAM-1.  Control non-coarcted aortas and control 
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aortas with a sham, non-constricting clip, showed low levels of VCAM-1 expression in 
the comparable downstream regions (figure 4.7).  Coarctation aortas with a nitinol clip 
showed a significant increase in VCAM-1 expression in the disturbed flow region 
downstream from the coarctation.  This increase in VCAM-1 expression was comparable 
to VCAM-1 expression in regions of chronically disturbed flow and significantly higher 
than regions of unidirectional laminar flow (figure 4.8).  
 We further investigated the correlation of ICAM-1 expression to regions of 
disturbed flow (figure 4.9).  We found that similar to previously published results, 
ICAM-1 expression increased in regions of chronically disturbed flow, specifically 
opposite the flow divider at the brachiocephalic branch [20].  Unexpectedly, we found 
that ICAM-1 expression did not increase in response to acutely induced low magnitude 
oscillatory WSS downstream from the coarctation.  This was a notable difference from 
the expression pattern of VCAM-1. 
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Figure 4.7 – VCAM-1 Expression in Coarctation Mice – VCAM-1 expression in 
control animals and animals treated with a sham, non-constricting clip, had low levels of 
VCAM-1 expression in the downstream region.  VCAM-1 expression increased 





Figure 4.8 – Regional VCAM-1 Expression in Coarctation Mice - VCAM-1 
expression increased in the inner curvature of the aortic arch and downstream from the 
nitinol clip induced coarctation.  Low basal levels of VCAM-1 expression were observed 




Figure 4.9 – Regional ICAM-1 Expression in Coarctation Mice – ICAM-1 expression 
is relatively low in the thoracic aorta and downstream from the coarctation.  A significant 
increase in ICAM-1 expression is apparent in the brachiocephalic branch opposite the 
flow divider.  The bottom panels show representative confocal images from each 
location. n=8-10 *=p<0.05 
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Transcription Factor Expression and Activation 
 Previous in vitro studies have found that the transcription factor, NFκB, increases 
expression and activation in response to low magnitude oscillatory WSS [98, 127].  We 
measured expression of the NFκB subunit, p65, in our coarctation model (figure 4.10).  
Low levels of expression were measured in the upstream region and in regions of 
chronically disturbed flow.  We found that there was no significant change in p65 
expression downstream from the coarctation though there was a slight trend for an 
increase in expression.  Qualitatively, in the downstream region, there appeared to be 




Figure 4.10 – NFκB expression in Coarctation Mice - There as no significant change 
in p65 expression in any of the three regions, though a slight trend for increased p65 
expression in the downstream region was apparent.  The lower panels show 
representative confocal images of p65 staining (pink) and DAPI staining (blue).  We 
observed a trend in the downstream region for increased localization of p65 staining in 
the nucleus.  This is representative of increased NFκB activation. n=4  
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Superoxide Levels in Response to Low Magnitude Oscillatory WSS 
Superoxide levels were quantitatively measured in the endothelium of mice using 
a novel hydro-Cy3 dye (Figure 4.11).  Low basal levels of superoxide were observed in 
the upstream region of the coarctation, corresponding to high magnitude unidirectional 
flow.  In regions of chronically disturbed flow, such as the brachiocephalic branch, there 
was a trend for an increase in superoxide generation.  Animals with a coarctation 
experience a region of low magnitude oscillatory WSS downstream from the coarctation.  
In this downstream region, superoxide levels were increased nearly four-fold in 
comparison to the control group and nearly two-fold in comparison to the chronically 
disturbed flow region. 
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Figure 4.11 – Hydro-Cy3 Measurements of Superoxide Generation in the 
Endothelium – Superoxide levels are relatively low in the upstream region of the aorta.  
In areas of chronically disturbed flow, such as the brachiocephalic, there is a trend for an 
increase in superoxide generation.  There is a significant increase in superoxide 
generation downstream from the coarctation.  Representative confocal images from each 
region are presented.  
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Fatty Streak Formation  
 As a model of early lesion formation, we used apoE-/- mice on a normal chow for 
2 months with no clip, with a sham (non-constricting) clip, or with coarctation inducing 
clip.  Aortas from these mice were stained with Oil Red O then imaged to quantify fatty 
streak formation.  Low levels of fatty streaks formed in the control animals and animals 
with a sham, non-constricting, clip.  Fatty streak formation significantly increased in the 




Figure 4.12 – Fatty Streak Formation Measured by Oil Red O Stain - ApoE-/- mice 
were fed a western diet for eight weeks.  Mice either had no surgery, a sham clip, or a coarctation 
clip.  Mice with a coartation clip showed a significant increase in fatty streak formation in the 
region downstream from the coarctation.  The lower panels show representative images of aortas 
stained with oil red o from animals with a sham clip (lower left panel) or a coarcting clip (lower 
right panel).  n=5  *=p<0.05 
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Discussion 
We developed two hypotheses to address this aim.  First, we hypothesized that 
inflammatory proteins would increase in vivo, in the regions of acutely induced low 
magnitude oscillatory WSS.  Additionally, we hypothesized that there would be distinct 
increases in NFκB and superoxide, that would be present in the acute model, but not in 
the chronic model.  Our objective to address these hypotheses was to characterize the 
acute and chronic response of atherogenic markers in regions of low magnitude 
oscillatory WSS.  We quantitatively measured expression of VCAM-1, ICAM-1 and 
NFκB using quantum dot nanoparticles with immunohistochemistry techniques.  We also 
measured superoxide levels using a novel superoxide sensitive dye, hydro-Cy3.  We 
found that in regions of acutely induced low magnitude oscillatory WSS there was an 
increase in expression of VCAM-1, increased superoxide levels, and increased expression 
and activation of NFκB.  In regions of chronically disturbed flow, superoxide levels were 
slightly increased, expression of cellular adhesion molecules was upregulated, and there 
was no change in NFκB expression or activation.  Additionally, we show that fatty 
streaks form in the region downstream from the coarctation over a chronic time course.  
From these results we determined two main conclusions. 
We conclude that the in vivo endothelial phenotype associated with acutely 
disturbed flow is characterized by increased production of superoxide and increased 
expression of select inflammatory proteins. In comparison, the phenotype associated with 
chronically disturbed flow is characterized by a more modest increase in superoxide and 
increased levels of multiple inflammatory proteins.  
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Utilizing the combination of the coarctation and aortic arch in the same mouse, 
we have established a powerful technique to analyze mechanotransdcution pathways.  
Much of the current literature has been obtained using in vitro, cell culture, techniques.  
There are some key limitations; however, a major difference between in vivo and in vitro 
settings is the time course involved.  Recently, in vitro studies have begun extending the 
time course of experiments to 72 hours [124].  This allows the cells to reach what is 
considered a stable equilibrium.  Most in vivo models have drastic differences compared 
to in vitro models, especially with regards to the time course.  Our coarctation model is 
able to analyze the mechanotransduction response on an acute time course similar to the 
72 hour in vitro studies, as well as the chronic time over the life of the mouse that is 
consistent with most in vivo models.  We have shown that there are distinct phenotypic 
differences between the acute and chronic time course particularly when considering 
unstable and transiently expressed molecules. 
We used a novel superoxide sensitive dye, hydro-Cy3, to look at endothelial 
superoxide levels in regions of acutely and chronically disturbed flow.  The current gold 
standard for superoxide detection in tissue is with DHE staining; however, DHE requires 
complex purification prior to use, it has a short half life, and it is light sensitive.  
Superoxide is a highly unstable and short lived molecule which rapidly reacts with other 
cellular molecules, such as SOD and NO.  It is challenging to employ this unstable dye to 
detect an unstable molecule, particularly when trying to image small localized regions in 
the endothelium.    Additionally, DHE has not been used for histology of whole tissue 
preparations of en face mounted tissue.  Previous attempts by our group to measure 
superoxide levels using DHE for en face histology have proved unsuccessful (data not 
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shown).    One reason is that whole tissue preparations require the tissue, and thus the 
dye, to be exposed to light during mounting which is not optimal for DHE use.  This 
results in high levels of background noise (poor signal to noise ratio) due to the increased 
oxidation of DHE.  Therefore, we used the hydro-Cy3 dye, which is more stable than 
DHE, to measure regional tissue levels of endothelial superoxide.    
We present a novel use of the hydro-Cy3 dye to quantitatively measure 
endothelial superoxide levels in regions of varying WSS.  We found that superoxide 
levels increase significantly in regions of low magnitude oscillatory WSS as compared to 
regions of high unidirectional WSS, similar to published data from in vitro studies [59, 
60, 66-68].  Previous reports, have demonstrated the specificity of the dye in vitro by 
using tempol as a means to scavenge superoxide molecule [58].  In aim III we will use 
pharmacological treatments to confirm the specificity of the dye.   
Numerous cell culture studies have shown an increase in oxidative markers in 
response to low magnitude oscillatory WSS [59, 67, 68, 128].  These results better 
correlate to the results we report from the acute model of disturbed flow than the chronic 
model of disturbed flow.  A clear similarity between the acute model and the in vitro 
studies is the time course: 72 hrs or less for in vitro studies compared to 72 hours for 
acute study, while the chronic time course lasts the entire life of the animal, i.e. months.  
In a chronic model, the unstable ROS would require continuous production and there 
would need to be a shift in the balance between oxidative sources and anti-oxidants.  On 
the other hand, the acute model might initiate an immediate increase in oxidative sources 
with a delayed response of antioxidants.  It has been suggested that feedback mechanisms 
might help to stabilize the system such that it will eventually equilibrate as opposed to 
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experiencing amplification of oxidative stress.  The fact that additional stimulus is needed 
to progress to lesion development suggests that there may be an equilibration with 
feedback compensatory mechanisms.  Future work to characterize the differences 
between the acute and chronic response and any compensatory mechanisms would be 
immensely valuable.   
Transcription factors have been shown to be expressed and activated in vitro in 
response to low magnitude oscillatory WSS [98, 99].  Additionally, in vivo studies have 
found increased p65 expression in high prone regions near the aortic sinus and inner 
curvature of the arch [101, 124].  Our results, however, showed no change in NFκB 
expression in regions of either acutely or chronically disturbed flow.  One difference 
between our results and the in vitro studies was that the in vitro studies were using 30 
minute time course while we used 72 hours for the acute time course and a chronic time 
course.  Transcription factors are very likely transiently expressed, and it is possible that 
this short time course could account for the differences observed.  A difference between 
our results and previous in vivo studies is that we were looking at the brachiocephalic 
branch while Hajra et al. analyzed the lesion prone region of the lesser curvature of the 
aortic arch [101].  Though both areas are characterized by low magnitude oscillatory 
WSS, it is possible that there may be other differences between these locations.  Both our 
study and Hajra et al., however, reported that there was no increase in NFκB activation in 
regions of chronically disturbed flow [101].  Hajra et al. reported that an additional 
stimulus, either LPS treatment or high fat diet, resulted in the activation and translocation 
of NFκB to the nucleus and this response was only observed in regions prone to lesion 
formation [101].  Other studies have further investigated NFκB in relation to lesion 
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formation showing that NFκB deficiency in the endothelium results in attenuated lesion 
area [129].  It is important to note however, that blocking NFκB in other cell types 
resulted in changes in the composition within the lesion or even increased lesion 
formation [130, 131].  These results implicate NFκB as an atherogenic molecule in the 
endothelium; however, the time course involved (30 min to 72 hours to chronic) may 
influence expression and activation as well as the presence of an additional atherogenic 
stimulus.  It is clear that NFκB plays a complex role in atherosclerosis and 
mechanotransduction and further research is needed. 
NFκB is one of the primary transcription factors leading to increased expression 
of cellular adhesion molecules.  These adhesion molecules are significantly more stable 
than either transcription factors or ROS, and we therefore expected sustained expression 
of both VCAM-1 and ICAM-1 in a region of chronically disturbed flow.  Our results 
confirm the previous findings that expression of both VCAM-1 and ICAM-1 is 
upregulated in the lesser curvature of the aortic arch where flow is chronically disturbed 
[20].  However, we found that VCAM-1 expression, and not ICAM-1 expression, is 
upregulated in response to acutely disturbed flow downstream from the coarctation.  
VCAM-1 has been shown to be a requisite mediator of flow dependent lesion formation 
in the aortic arch of VCAM-1 deficient (D4D) mice [111].  ICAM-1 knockout mice on 
the other hand, have been shown to have reduced lesions throughout the entire aorta but 
not in regions of flow mediated lesion formation [132].  These results, along with our 
results, implicate VCAM-1 in the early and acute stages of atherogenesis.  Additionally, 
it suggests that VCAM-1 is a requisite mediator for flow induced lesion localization 
while ICAM-1 is not, at least in the time frame considered for this study.    
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The acute and chronic time course from the coarctation and aortic arch models 
respectively, likely provide insight into slightly different pathologies.  The chronic time 
course is likely similar to the progression of atherosclerosis.  Atherosclerosis is a multi-
stage and multifactoral disease that develops over a long time course.  The chronic 
envrironment in the lesser curvature of the aortic arch has been described as athero-
susceptible, though it is in an equilibrated and stable state in the absence of other factors.  
It is plausible that feedback mechanisms might help to stabilize the system such that it 
eventually equilibrates as opposed to experiencing an amplification of oxidative stress.  
This environment is ideal for investigating the progression of lesion formation in a flow 
dependent manner; however, it does not accurately represent the mechanotransduction 
mechanisms in response to disturbed flow.  Alternatively, the acute model better 
investigates the in vivo mechanotransduction of low magnitude oscillatory WSS.  There 
may still be compensatory mechanisms and parallel pathways, that are not present in the 
in vitro setting, though these may be different then temporal compensatory mechanisms 
observed in the chronic model.  Investigating both the acute and chronic response and, in 
particular, the compensatory mechnisms that lead to the equilibrated chronic state may 
provide new directions for treatments of atherosclerosis lesion formation. 
There are inherent limitations in using a stenosis/coarctation as our model of 
disturbed flow, particularly with the assumption that WSS is the primary stimulant to any 
molecular endothelial response.  Using the physical clip prevents any compliance within 
the stenotic region and alters the strain in the immediately adjacent region.  Our area of 
interest is downstream from the clip in a region where the compliance has returned to the 
physiologic conditions as determined by our compliance measurements from aim I.  
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Additionally, we see minimal pressure drop across our coarctation.  We therefore assume 
that we are not producing a large change in strain, either from a change in pressure or 
from the physical constraint, and therefore, we assume that WSS is the primary 
mechanical stimulant in our model.  Another limitation inherent in the 
stenosis/coarctation model is that there is a change of the biotransport of both cells and 
molecules in the lumen of the vessel near the wall.  This results in increased exposure 
time of these molecules and cells to the vessel wall.  All regions of low magnitude 
oscillatory WSS will experience this biotransport phenomena and it is a product of the 
pathologic disturbed flow environment.  We cannot feasibly isolate the mechanical 
stimulus from the biotransport stimulus, and we must therefore make the assumption that 
the primary stimulant is from the change in the mechanical force.  Another limitation due 
to the mechanical environment is that the region of interest is very small and limits the 
available molecular analysis techniques.  This model is ideal for use with quantitative 
staining methods since techniques such as PCR and western blots would be challenging 
to isolate cells from the region of interest and likely require pooling of a substantial 
number of mice.  We use quantitative analysis techniques with highly stable quantum 
dots and a novel superoxide sensitive fluorophore.   
We are additionally limited in our choice of markers that we can measure.  Of 
particular interest to us would be hydrogen peroxide.  NOX family members can directly 
produce hydrogen peroxide, and SOD scavenges superoxide thereby generating hydrogen 
peroxide.  We therefore would ideally want to investigate the response of hydrogen 
peroxide in our model.  However, we are limited due to the lack of accurate methods for 
the measurement of hydrogen peroxide.  Hydrogen peroxide is challenging to measure in 
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vivo and more challenging to measure specifically in the endothelium.  The dye DCF-DA 
is sometimes used to measure hydrogen peroxide levels; however, recent reviews have 
shown evidence for the instability of the molecule resulting in high levels of background 
noise and photobleaching during imaging [54].   
 In summary, we present a novel model in which we can compare molecular 
signaling in response to acutely and chronically disturbed flow.  We show that there are 
distinct endothelial phenotypes associated with either chronically disturbed flow or 
acutely disturbed flow.  In conditions of acutely disturbed flow we show an increase in 
superoxide levels, a trend for an increase in NFκB expression and activation, and an 
increase in VCAM-1 expression.  In regions of chronically disturbed flow we show a 
trend for an increase in superoxide levels, no change in NFκB, and a significant increase 
in both VCAM-1 and ICAM-1.  NFκB in particular has been implicated as a critical 
factor in the phenotypic difference between the acute state and the chronic state.  
Additionally, NFκB may play a role in the transition from an atherosusceptible, but 
stable, chronic state to a pathologic state progressing to lesion development.  There are 
still many other mediators of mechanosensitive pathways that have been identified in 
vitro.  These results demonstrate the importance of confirming in vitro findings within in 
vivo settings and in particular to consider the involved time course.  This in vivo model 
additionally allows for the investigation of the functional contribution of various 
mechanosenstivite markers, which we will analyze in the third aim using genetically 




Investigate redox signaling mechanisms in the mouse coarctation model 
Introduction 
For our final aim, our objective was to use a combination of genetic models and 
pharmacological inhibitors, to investigate if a causal relationship exists by which ROS 
mediates WSS transduction to induce inflammatory protein expression.  ROS have been 
implicated as important mediators in the flow dependent localization of atherosclerotic 
lesion formation.  In aim II we showed that superoxide levels increase in regions of low 
magnitude oscillatory WSS.  Similar findings have been published from in vitro 
experiments.  Endothelial cells acutely exposed to low magnitude oscillatory WSS in cell 
culture have increased expression of Nox 1, Nox 2, and Nox 4 along with increased 
superoxide levels [59, 60, 66-68].  This shear dependent superoxide generation is 
attenuated in cells from p47 phox-/- mice, or by treatment with either siNox1 or 2-DOG, 
an inhibitor of the pentose shunt pathway for NADPH production [66-68].  Supporting 
the in vitro data, in vivo studies have also shown that acute induction of low magnitude 
oscillatory WSS in a partial carotid ligation model induces atherosclerotic lesion 
formation, which can be attenuated in p47 phox-/-  mice.  These data together suggest that 
superoxide is generated in response to low magnitude oscillatory WSS through an 
NADPH oxidase mechanism and in particular implicate the involvement of Nox 2.  
Additional studies have implicated this increase in ROS levels as a critical 
mechanotransduction signaling event leading to initiation of an inflammatory response 
and atherosclerotic lesion development.     
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 In aim II we showed that there was increased expression of VCAM-1 in regions 
of low magnitude oscillatory WSS.  There is evidence that antioxidant treatment can 
attenuate increased expression of VCAM-1, suggesting that ROS mediate VCAM-1 
expression in response to low magnitude oscillatory WSS [98, 102, 108].  It is further 
known that VCAM-1 expression is an important mediator of lesion formation.  In vivo 
flow studies have shown that VCAM-1 expression increased in regions of chronically 
low magnitude oscillatory WSS and that deficiency in VCAM-1 attenuated lesion 
formation [20, 22, 27, 111, 112].  The in vitro data implicate ROS as mediators of shear 
dependent VCAM-1 expression, while the in vivo data implicate both ROS and VCAM-1 
in WSS dependent lesion formation.  It is important to note that the data on the involved 
molecular mechanisms come primarily from in vitro studies and little is known about the 
functional relevance of this data to in vivo conditions.  The varying cell types (MAECS, 
HUVECS, or BAECS), time courses (6 hours to 72 hours), flow environments, culture 
conditions, and environmental factors in vitro  and in vivo study essential for determining 
the molecular mechanisms that mediate shear induced expression of cell adhesion 
molecules.   
These data led us to hypothesize that in an in vivo model of low magnitude 
oscillatory WSS, superoxide levels would increase in an NADPH oxidase dependent 
manner and that this increase in superoxide would then mediate shear dependent VCAM-
1 expression.  
Our primary objective was to investigate whether either superoxide or hydrogen 
peroxide mediates the increase in VCAM-1 expression observed in regions of low 
magnitude oscillatory WSS.  Our secondary objective for this aim was to determine the 
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source for WSS induced superoxide generation.  We used a combination of transgenic 
animal models and reagent treatments to investigate the source of endothelial superoxide 
and show the specificity of the dye hydro-Cy3 dye.  We then measured VCAM-1 
expression in these same animal models to determine the contribution of ROS to shear 
dependent VCAM-1 expression.  Figure 5.1 shows the proposed pathway and highlights 
the targets from our transgenic animals and pharmacological inhibitors.  We used p47 
phox-/- mice, catalase overexpressing mice, mice treated with the SOD mimetic tempol, 
and mice treated with the glutathione peroxidase mimetic ebselen. 
 
Figure 5.1 – Proposed Pathway of Shear Dependent Mechanotransduction -  
Transgenic animals and pharmacological inhibitors will be used to diminish ROS levels.  
The oxidative sources in the red boxes are the targets of the animal models.  We 
measured superoxide levels and VCAM-1 expression in these models. 
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Methods 
Animals   
Male C57BL/6 mice were purchased from Jackson Laboratories, (Maine, USA).  
P47 phox-/- mice and the corresponding C57BL/6 controls were purchased from Taconic 
Farms, Inc. (New York, USA).  Catalase overexpressing mice were bred in house in the 
Department of Animal Resources at Emory University.   These mice have increased 
expression of human catalase in vascular tissue through the endothelial specific, Tie-2, 
promoter (These mice come from Dr. Harrison and Dr. Kojda) [133].  Tempol (4-
Hydroxy-TEMPO, Sigma Aldrich) was administered in drinking water at a concentration 
of 1mM, a commonly used dose [134, 135].  In another sample group, tempol was 
administered intravenously by osmotic mini-pump at a rate of 40*10-6 mol/kg/min. This 
dose used the same concentration (100mM) previously used for osmotic mini-pumps, but 
using a pump with an increased pumping rate of 9.89 µL/hr [135-137].  Both modes of 
administration were performed with a one day pretreatment, before surgery, and then 
continued for the 72 hour time course (total of 4 days treatment).  Ebselen (Sigma 
Aldrich) was administered by osmotic mini-pump subcutaneously at a rate of 10 
mg/kg/day.  To get ebselen into solution it was first dissolved in DMSO which was then 
mixed with saline to a final concentration of 50% DMSO by volume.  Control mice were 
given mini-pumps with 50% DMSO by volume, the same DMSO concentration used for 
the ebselen treatment group.  Male mice aged 11-13 weeks were used for this study.  The 
animals were housed and cared for according to the guidelines approved by the Emory 
University Institutional Animal Care and Use Committee. 
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Osmotic mini-pump implantation  
Mice were anesthetized using isoflurane (oxygen delivered at 0.5L/min with 3% 
isoflurane for induction and 1.5% isoflurane for maintenance). For tempol pumps, fur 
was removed using a dilapatory (Nair) and an incision was made in the neck to expose 
the jugular vein. A jugular catheter attached to a primed osmotic mini-pump (Alzet 
osmotic mini-pump 2ML1, Durect Corporation, Cupertino, CA) was inserted and tied 
into the jugular vein and the pump inserted subcutaneously at the back of the neck. The 
neck and back were sutured closed and mice were administered buprenorphine as needed.  
For ebselen pumps, the fur was removed from the back, a small incision was made, and 
the pump (Alzet osmotic mini-pump 1007D) was implanted subcutaneously. 
Coarctation Surgery  
Procedures were performed as described in aim I.  
Hydro-Cy3 Staining  
Procedures were performed as described in aim II.  
En Face Quantum Dot Immunohistochemistry  
Procedures were performed as described in aim II.  
Microscopy and Quantification of Fluorescence Intensity   
Procedures were performed as described in aim II.  
Electron Spin Resonance  
Plasma tempol concentrations were quantified by electron spin resonance 
spectrometry. Mouse plasma samples were separated from whole blood by centrifugation 
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and then stored at -80ºC.  Thawed plasma samples were taken up into a glass capillary 
tube and placed into a Bruker EMX electron spin resonance spectrometer.  Tempol 
produces a characteristic 3-peak spectra and the concentration of tempol is relative to 
peak intensity.  Tempol concentration was quantified by measuring the intensity of the 
first peak.  A standard curve was produced by measuring the intensity of the peak from 
standard tempol concentrations.  Intensity measurements were then obtained for plasma 
samples and the standard curve was used to accurately quantify the concentration of 
tempol in the plasma sample.  [138]  
Statistics  
Quantitative results were analyzed with a one-way ANOVA using GraphPad 
Prism software (GraphPad Software, La Jolla, CA).  Results are shown as mean ± SEM.  




Specificity of Hydro-Cy3 
Specificity and background noise have been limiting factors in previous attempts 
to measure superoxide in the endothelium.  We administered tempol, an SOD mimetic 
that scavenges superoxide, to demonstrate the specificity of the hydrocyanine dye.  We 
used ESR to determine the plasma levels of tempol after administration in the drinking 
water.  Tempol administration in drinking water (1mM) resulted in a mean plasma tempol 
concentration of 46.9 ± 22.6 nM (figure 5.2).  Superoxide levels in coarctation mice 
treated with tempol by drinking water were the same in the upstream and downstream 
regions, as compared to the respective regions in control mice.  In a separate group of 
mice, tempol was administered intravenously by osmotic mini-pump (40*10-6 
mol/kg/min).  This dose produced a mean tempol plasma concentration of 383.1 ± 45.3 
µM, significantly higher than the plasma concentration after drinking water 
administration.  Superoxide levels in coarctation mice in the mini-pump group were 
significantly attenuated in comparison to the respective regions in control mice; levels in 
the upstream region were reduced by 79%, levels in the downstream region were reduced 
by 63% and levels in the brachiocephalic branch opposite the flow divider were reduced 
by 70% (figure 5.3 & figure 5.4).  Downstream superoxide levels after treatment of 
tempol by mini-pump were comparable to the upstream superoxide levels in the control 
animals.   
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Figure 5.2 – ESR Measurements of Plasma Concentrations of Tempol - Tempol 
administration through drinking water (1mM) produced plasma tempol concentrations 
that were significantly lower than the plasma concentrations when tempol was 




Figure 5.3 – Superoxide Levels in Tempol Treated Mice - Tempol treatment 
administered through the drinking water produced no change in superoxide levels in 
either the upstream or downstream region when compared to the control.  Tempol 
treatment by osmotic mini-pump significantly attenuated the superoxide levels in the 
upstream and downstream regions in comparison to the control.  Representative confocal 
images from en face mounted aortas are presented on the bottom of the figure: A,C and E 
are from the upstream region, B, D, F are from the downstream region from a coarctation 
aorta, A and B are from control mice, C and D.are from mice treated with tempol 
administered by drinking water, E and F are from mice treated with tempol administered 
by mini-pump.  n=6-8, *=p<0.05 comparing upstream regions of the three group, 
**=p<0.05 comparing downstream regions of the three groups. 
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Figure 5.4 – Superoxide Levels in Regions of Chronically Disturbed Flow in Tempol 
Treated Mice and p47 Phox-/- Mice - Superoxide levels were relatively high in the 
region of chronically disturbed flow in both  control and p47 phox-/- mice.  Superoxide 
levels were significantly decreased in the same region in mice treated with tempol by 
osmotic mini pump.  n=5, *=p<0.05  
Superoxide as a Shear Sensitive Signaling Molecule 
 Tempol treated mice (drinking water and mini-osmotic pump) were used with our 
coarctation model to investigate the role of superoxide as a mediator of VCAM-1 
expression in response to changes in WSS.  In control mice with no tempol treatment, 
VCAM-1 expression was relatively low in the upstream region, where cells were exposed 
to high magnitude unidirectional WSS (figure 5.5).  VCAM-1 expression significantly 
increased in the downstream region that was acutely exposed to low magnitude 
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oscillatory WSS.  Mice treated with tempol administered through drinking water showed 
the same VCAM-1 expression in both the upstream and downstream regions as compared 
to the respective regions in the control, non-tempol treated, mice.  Similarly, mice treated 
with tempol administered intravenously by mini-pump, showed no significant change in 
VCAM-1 expression in either the upstream or downstream region as compared to control, 
non-tempol treated, mice.  The tempol dose achieved by intravenous infusion was enough 
to attenuate the endothelial superoxide levels, but had no effect on vascular VCAM-1 
expression in the downstream region.  There was a trend for a decrease in VCAM-1 
expression in the brachiocephalic branch opposite the flow divider in mice treated with 





Figure 5.5  – VCAM-1 Expression in Mice Treated with Tempol -  Tempol treatment, 
regardless of mode of administration, had no effect on VCAM-1 expression in either the 
upstream region or the downstream region when compared to the control.  Representative 
confocal images from en face mounted aortas stained for VCAM-1 are presented.  A,C, 
and E are from the upstream region, B, D, F are from the downstream region from a 
coarctation aorta, A and B are from control mice, C and D.are from mice treated with 
tempol administered by drinking water, E and F are from mice treated with tempol 




Figure 5.6 – VCAM-1 Expression in Regions of Chronically Disturbed Flow in 
Tempol Treated Mice and p47 phox-/- Mice - VCAM-1 expression was relatively high 
in the control mice.  There was a trend for attenuated VCAM-1 expression in p47 phox-/- 
mice and mice treated with tempol by mini-pump, though neither reached significance.  
n=3 for the p47 phox-/- ; n=5 for the c57 group; n=5 for the tempol - mini-pump group 
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Contribution of NADPH Oxidase 
The coarctation model was used with p47 phox-/- mice to investigate the 
contribution of NADPH oxidase to shear-dependent endothelial expression of both 
superoxide and VCAM-1.  There was no significant difference in superoxide levels in the 
upstream region between the p47 phox-/- mice and the control mice (figure 5.7).  The 
superoxide levels increased significantly in the downstream region in both groups of 
mice, with a trend for an attenuated signal in the p47 phox-/- mice, which did not reach 
statistical significance.  Similarly, superoxide levels in a region of chronically disturbed 
flow in p47 phox-/- mice showed no difference between a comparable region in control 
mice.    
VCAM-1 expression followed a similar pattern to that of superoxide. Superoxide 
expression upstream was comparable between control and p47 phox-/- mice.  Expression 
downstream increased significantly in both groups in comparison to the upstream region.  
There was a slight trend for attenuated VCAM-1 expression in the downstream region of 
p47 phox-/- mice as compared to the control, though the attenuation did not reach 
significance (figure 5.8).  Similarly, there was an increase in VCAM-1 levels in the 
brachiocephalic branch as compared to the upstream region in p47 phox-/- mice (figure 
5.6).  There was a trend for a slightly attenuated level of VCAM-1 expression in the 
brachiocephalic region in p47 phox-/- mice as compared to control mice, though this did 




Figure 5.7 – Superoxide Levels in p47 Phox-/- Mice - p47 phox-/- mice showed 
superoxide levels that were comparable to the control in both the upstream and 
downstream regions.  Representative confocal images from en face mounted aortas are 




Figure 5.8 – VCAM-1 Expression in p47 Phox-/- Mice - There was no significant 
change in VCAM-1 expression in either the upstream or downstream regions when 
compared with the control.  Representative confocal images are shown: A and C are from 
the upstream region, B and D are from the downstream region, A and B are from control 
mice while C and D are from p47 phox-/- mice. n=6-8, *=p<0.05 comparing upstream 
region to downstream region. 
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Contribution of Hydrogen Peroxide 
We used two complimentary murine models of decreased hydrogen peroxide 
levels, to further investigate the contribution of ROS to WSS dependent VCAM-1 
expression.  Transgenic mice over-expressing catalase in the vascular wall, showed a 
trend for attenuated VCAM-1 expression in the upstream region compared with the 
control.   However, VCAM-1 expression in the downstream region of the catalase 
overexpressing mice increased significantly compared with the upstream region and was 
not significantly different from that of the control (Figure 5.9).  Similarly, ebselen treated 
mice, showed attenuated VCAM-1 expression in the upstream region compared to the 
control, yet expression in the downstream region increased to a level comparable to that 
of the control.  In the region of chronically disturbed flow, VCAM-1 expression 
increased in comparison to the upstream region in the catalase mice.  This level was 
comparable to the increase observed in the control mice.  The ebselen treated mice also 
showed an increase in the brachiocephalic region in comparison to the upstream region of 
the ebselen treated mice.  However, the VCAM-1 levels were significantly lower in the 
brachiocephalic branch of the ebselen treated mice in comparison to the same region in 
the control mice. 
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Figure 5.9 – VCAM-1 Expression in Catalase Overexpressing Mice and Ebselen 
Treated Mice - There was no significant change in VCAM-1 expression in the upstream 
or downstream regions from either treatment group when compared with the control.  
Representative confocal images from en face mounted aortas stained for VCAM-1 are 
presented.  A,C, and E are from the upstream region, B, D, F are from the downstream 
region from a coarctation aorta, A and B are from control mice, C and D.are from 
catalase overexpressing mice, E and F are from mice treated with ebselen.  n=6-8, 
*=p<0.05 comparing upstream region to downstream region. 
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Figure 5.10 – VCAM-1 Expression in Regions of Chronically Disturbed Flow in 
Animal Models of Decreased Hydrogen Peroxide Levels -  The control animals had 
relatively high levels of VCAM-1 expression in regions of chronically disturbed flow that 
were comparable to the VCAM-1 expression in the same region of catalase 
overexpressing mice.  Mice treated with ebselen had significantly decreased VCAM-1 
expression in regions of chronically disturbed flow.  n=4-6  *=p<0.05 
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Contribution of NFκB 
NFκB was implicated as a mediator in our hypothesized pathway in which ROS 
mediated WSS induced VCAM-1 expression.  We used p65-/- mice to investigate the 
contribution of NFκB to VCAM-1 expression in the aortic coarctation model.  There 
were relatively low levels of VCAM-1 expression in the upstream region which 




Figure 5.11 – VCAM-1 Expression in p65-/- Mice - VCAM-1 expression increases 
downstream from the coarctation in control and p65-/-  mice. n=2-3  *=p<0.05 
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Discussion 
We hypothesized that in an in vivo model of low magnitude oscillatory WSS, 
superoxide levels would increase in an NADPH oxidase dependent manner and that this 
increase in superoxide would then mediate shear dependent VCAM-1 expression.  Our 
primary objective was to investigate whether either superoxide or hydrogen peroxide 
mediates the increase in VCAM-1 expression observed in regions of low magnitude 
oscillatory WSS.  Our secondary objective for this aim was to determine the source for 
WSS induced superoxide generation.  We found that tempol was able to reduce 
superoxide levels given that tempol was delivered at a sufficient dose.  Though tempol 
was able to reduce superoxide levels, VCAM-1 still increased in regions of low 
magnitude oscillatory WSS in tempol treated mice.  Additionally, we found that p47 
phox-/- mice had endothelial superoxide levels and VCAM-1 expression that was 
comparable to the control mice independent of flow.  Finally, in models of decreased 
hydrogen peroxide levels, we found that VCAM-1 expression still increased in region of 
acutely disturbed flow.  However, ebselen treatment was able to reduce VCAM-1 
expression in regions of chronically disturbed flow in comparison to the control.  From 
these results we determined two conclusions. 
We conclude that in regions of acutely disturbed flow in vivo, VCAM-1 
expression is not modulated by reactive oxygen species.  Additionally, the NADPH 
oxidase subunit, p47 phox, does not mediate superoxide generation in response to 
disturbed flow. 
Previous reports have demonstrated the specificity of the hydrocy-3 dye in vitro 
by using tempol as a means to scavenge superoxide [58].  Similarly, we found that hydro-
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Cy3 measurements of endothelial superoxide levels could in fact be attenuated by 
treatment with tempol. However, it was necessary to modify the mode and dose of 
delivery to increase the plasma concentration to sufficient levels.  Previously, an in vitro 
dose response study showed that administration of tempol at a concentration on the order 
of 1mM inhibited 75% of superoxide production when stimulated with angiotensin II, 
while tempol concentrations on the order of 100 nM inhibited 10% of superoxide 
production [87].  Though the stimulus in our study was different (WSS instead of 
angiotensin II) the findings were similar.  Tempol treatment administered intravenously 
by mini-pump produced plasma concentrations on the order of 1mM and was able to 
attenuate superoxide levels.  However, tempol treatment administered in the drinking 
water produced plasma levels on the order of 100 nM and had no significant effect on 
observed endothelial superoxide production.  In future studies, it should therefore be 
taken into account that although tempol treatment in the drinking water has been shown 
to produce systemic effects, it does not sufficiently increase plasma tempol levels to a 
concentration where endothelial superoxide production is significantly inhibited. 
Though tempol treatment was able to attenuate endothelial superoxide levels in 
the upstream and downstream regions as compared to the control, it is important to note 
that there was still a significant increase in superoxide levels in the downstream region as 
compared to the upstream region.  However, the level of superoxide present was 
equivalent to the baseline levels seen in control animals. 
We quantitatively measured VCAM-1 using quantum dot based en face 
immunohistochemistry.  This methodology specifically quantifies endothelial protein 
expression as the quantum dot-antibody conjugates do not penetrate into the media of the 
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aorta [123].   In aim 2 we reported that VCAM-1 levels increased significantly in the 
downstream region as compared with the upstream region.  Tempol treatment, regardless 
of mode of administration, had no effect on the upstream or downstream expression of 
VCAM-1 as compared to the control.  Though the data from the region of chronically 
disturbed flow in tempol treated mice showed a trend for attenuated VCAM-1 expression, 
this trend did not reach significance.  These data suggest that superoxide does not 
mediate WSS induced changes in endothelial VCAM-1 expression in the aorta.  
 Since tempol treatment suggests that there may be differences between in vivo and 
in vitro signaling pathways, we wanted to investigate the mechanisms of shear dependent 
superoxide formation by looking at the in vivo contribution of the NADPH oxidase 
subunit, p47 phox.  Previous studies found that p47 phox had a functional role in shear 
dependent superoxide formation and subsequent inflammatory protein expression [27, 67, 
68, 128].  Our study, however, found that in p47 phox-/- mice, superoxide levels increased 
significantly in the downstream region as compared to the upstream region and neither 
region was significantly different from that of the control.  We specifically show this 
response in the endothelium, whereas previous in vivo studies may have been measuring 
superoxide produced by additional cell types, such as macrophages or smooth muscle 
cells.  Additionally, VCAM-1 expression in p47 phox-/- mice was comparable in all 
regions to the expression in control mice.  These results show that in vivo endothelial 
production of superoxide in response to low magnitude oscillatory WSS is not p47 phox 
dependent and suggest the presence of compensatory or parallel pathways in vivo.   
P47 phox-/- mice have some clear limitations with regards to analysis of the entire 
NOX family.  The p47 phox subunit is not present in all NOX family members, of 
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particular note is NOX 4.  NOX 4 in fact, has been shown to be upregulated in p47   
phox-/- mice [D. Sorescu, personal communication].  This compensatory mechanism 
could account for the lack of change in superoxide levels and may even produce an 
additional increase in other oxidants, primarily hydrogen peroxide.  Since in vitro studies 
had shown that p47 phox-/- cells attenuated superoxide production in response to low 
magnitude oscillatory WSS we chose this model as our focus [68].   
Alternative methods for investigating the NADPH oxidase family do exist, 
primarily the use of the inhibitors apocynin or DPI, yet these have their own limitations.  
Apocynin has been shown to stimulate ROS production in non-phagocytic cells [79].  In 
preliminary studies by our group, we saw increased basal VCAM-1 levels throughout the 
vasculature with apocynin use and thus chose not to pursue this path (data not shown).  
DPI, on the other hand, inhibits all flavin containing enzymes, including eNOS [50].  
eNOS is responsive to WSS and when uncoupled is believed to play a role in endothelial 
superoxide generation [139].  DPI is therefore not an ideal treatment when trying to 
isolate molecular mechanisms involving the NOX family from other oxidant producing 
enzymes.  Recent reviews of these treatments have discussed the lack of specificity of 
both reagents as well as the ability to produce oxidative stress and therefore recommend 
use of other means to investigate the NOX family [50]. 
Although compensatory and parallel mechanisms may be directly affecting 
superoxide levels in this model, it is also feasible that these pathways may also affect 
other oxidants.  Of particular interest is hydrogen peroxide.  NOX family members can 
directly produce hydrogen peroxide and SOD scavenges superoxide producing hydrogen 
peroxide.  We therefore wanted to investigate whether decreasing hydrogen peroxide 
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levels might inhibit inflammatory protein expression.  We found that VCAM-1 
expression was not attenuated in the downstream region in either catalase overexpressing 
mice or mice treated with ebselen.  We did however, see attenuated VCAM-1 expression 
in the chronically disturbed flow region in ebselen treated mice.  This level of expression, 
however, was still higher than upstream levels.   A limitation of these experiments is the 
lack of accurate methods for the measurement of hydrogen peroxide, therefore we cannot 
confirm the efficacy of the treatments.  Hydrogen peroxide is challenging to measure in 
vivo and more challenging to measure specifically in the endothelium.  The dye DCF-DA 
is sometimes used to measure hydrogen peroxide levels; however, recent reviews have 
shown evidence for the instability of the molecule [54].   
The last model that we used investigated the contribution of NFκB to VCAM-1 
expression in the coarctation model.  As was the trend in the other animal models, the 
NFκB-/- mice had a significant increase in VCAM-1 expression in the region of acutely 
disturbed flow, comparable to the control.  As described in the discussion for aim II, 
knocking out NFκB in different cells can have different consequences for atherogenesis.  
Reports have shown decreased lesion formation, a change in lesion composition or even 
increased lesion formation [129-131].  These results suggest multiple roles for NFkB in 
vivo, and could likely explain the differences between our data and previous in vitro 
studies. 
There were slight differences in the data from aim III in the chronic and acute 
disturbed flow regions.  In the acute disturbed flow region, inflammatory protein 
expression was completely independent from oxidative stress.  This implies that there 
must be other mechanisms by which shear stress is transduced resulting in inflammatory 
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protein expression. The data from the chronic region showed a trend for attenuated 
VCAM-1 expression in the downstream region from each of the models of decreased 
ROS, though it only reached significance in the ebselen treated group.  We therefore, 
suspect that ROS do play a role in chronically disturbed flow, but other pathways are still 
activated, whether parallel or compensatory.  It is known that oxidative stress contributes 
to atherosclerosis lesion formation in accelerated atherosclerosis mouse models.  
However, when specifically considering flow dependent lesion formation in regions such 
as the arch, there have been some differing results.  These data suggest that there may be 
parallel pathways that are activated during flow dependent lesion formation.  These data, 
along with our data suggest that flow dependent lesion localization occurs through a 
mechanotransduction mechanism independent of the redox state.  Future work might 
therefore investigate parallel or compensatory pathways by utilizing multiple antioxidants 
(e.g. target superoxide and hydrogen peroxide).   
An obvious limitation of this technique is that it is low throughput and can not 
look at many different markers.  We therefore focused on oxidants that had been shown 
to be responsive to low magnitude oscillatory WSS in prior studies.  Other inflammatory 
and oxidative markers of interest for future studies may include ICAM-1, BMP-4, eNOS, 
xanthine oxidase, and peroxynitrite, among others.  A recent in vivo study gives our 
group particular interest in investigating eNOS and the AT1R.  It was shown that AT1R 
expression increased in atheroprone regions which could be blocked in eNOS 
overexpressing mice [140].  This implicates another pathway by which low magnitude 
oscillatory WSS might stimulate an endothelial inflammatory response.     
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As a result of this study we conclude that shear dependent inflammatory protein 
expression occurs through a redox independent mechanism.  Superoxide is acutely 
responsive to low magnitude oscillatory WSS, as is VCAM-1.  In this model VCAM-1 
expression is not dependent on superoxide levels.  Furthermore, compensatory 
mechanisms or parallel pathways appear to exist in vivo in the shear dependent 
production of superoxide, such that this pathway is not dependent on p47 phox.  Though 
in vitro studies can provide valuable insight into molecular mechanisms involved in 
atherogenesis, it is still important to investigate these molecular mechanisms in vivo for 
greater understanding of the development of atherosclerotic plaques.  Finally, we show 
that models of decreased hydrogen peroxide do not inhibit acute shear dependent VCAM-
1 expression, but may attenuate VCAM-1 expression partially in a chronic time course.  
These data suggest that hydrogen peroxide may be involved in VCAM-1 upregulation as 
a result of disturbed flow, but it is not a critical component.  Mechanically induced 
oxidative stress is clearly a complex mechanism and further research is required to 




DISCUSSION AND FUTURE DIRECTIONS 
Discussion 
Aim I 
Our objective for this aim was to develop a novel mouse model of acutely 
disturbed flow.  We thoroughly characterized the hemodynamic environment associated 
with the coarctation induced by the nitinol clip.  Using a combination of techniques, in 
situ µCT and ex vivo pressure inflation, we showed that we can effectively constrict the 
aortic diameter at the clip with minimal variability.    We further showed that this 
constriction produced a minor stenosis with no significant pressure loss.  The CFD model 
showed that the coarctation produced low magnitude oscillatory WSS in the distal region.   
We concluded that coarctation of the descending aorta using a nitinol clip 
uniquely created a hemodynamic environment of low magnitude oscillatory WSS without 
a significant change in blood pressure.   
We found that the nitinol clip model produced an idealized stenosis.  We used 
µCT and ex vivo pressure inflation to demonstrate the efficacy of the nitnol clip.  The 
pressure inflation showed that we were able to induce an ideal stenosis under ex vivo 
conditions without interference from surrounding tissue.  However, after fixation at 100 
mmHg the tissue remained largely compliant and the unpressurized aortic diameter 
correlated to a diameter at a pressure of 10 mmHg as determined by the pressure diameter 
curves.  We speculate that the tissue was not fixed at the morphology corresponding to 
the fixation pressure because the mouse aorta is very thin and the composition of the 
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vessel is high in elastin compared to collagen.  To correct for this error, we determined an 
expansion factor from the pressure diameter curves.  We applied these expansion factors 
in silico to the aortic diameter of the µCT reconstruction.  When the expansion factor was 
applied to expand the tissue to an aortic diameter comparable to the diameter during 
diastole, about 60 mmHg, a significant stenosis was observed.  We used the in silico 
expanded aorta for the CFD modeling. 
The CFD model showed results as predicted by the idealized stenosis model.  
Flow was unidirectional during the upstroke of systole, flow separation occurred during 
the downstroke of systole, and then was again unidirectional during diastole.  WSS was 
high upstream from the coarctation, increased further in the stenotic region, then 
decreased significantly downstream from the coarctation.  Additionally, we showed that 
there was no significant pressure loss produced by the coarctation.  Therefore we predict 
that there is no significant change in strain on the endothelial cells and that the primary 
mechanical stimulus of the model is the change in WSS.  These results demonstrate a 
model with significant advantages over current in vivo murine models of WSS. 
The comparable murine flow models are the carotid coarctation reported by 
Cheng et al. and the carotid partial ligation reported by Nam et al. [25, 27].  Our model 
produces a unique model of low oscillatory WSS with minimal disturbances to pressure 
and therefore strain.  The carotid coarctation model reports a region of low magnitude 
unidirectional WSS and a region of high magnitude oscillatory WSS [25].  Furthermore, 
this model does not characterize any alterations to pressure and/or strain.  The partial 
ligation model reports low magnitude oscillatory WSS, but does not characterize pressure 
and/or strain.  The low flow in this model likely produces a moderate change in strain 
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which could modulate the biological response.  These distinct differences in the 
mechanical environments of the three models and the limitations of each model provide 
unique in vivo models to investigate different biological responses. 
We conclude that this study presents a novel model of acutely disturbed flow.  
The model utilizes the shape memory response of a nitinol clip to induce an aortic 
coarctation with high reproducibility.  We showed low magnitude oscillatory WSS in the 
region distal to the coarctation.  This model can be used in future studies without the need 
for further validation of the flow environment and will significantly increase the 
accessibility of in vivo experiments addressing mechanical transduction.  This model 
provides a number of advantages over existing in vivo  mouse models of disturbed flow 
including: ease of use, high reproducibility, low mortality rate, an acute time course, and 
a fully defined hemodynamic environment exhibiting low magnitude oscillatory WSS.   
Aim II 
We developed two hypotheses for aim II.  First, we hypothesized that 
inflammatory proteins would increase in vivo, in the regions of acutely induced low 
magnitude oscillatory WSS.  Additionally, we hypothesized that there would be a distinct 
increases in NFκB and superoxide, that would be present in the acute model, but not in 
the chronic model.  Our objective to address these hypotheses was to characterize the 
acute and chronic response of atherogenic markers in regions of low magnitude 
oscillatory WSS.  We found that in regions of acutely induced low magnitude oscillatory 
WSS there was an increase in expression of VCAM-1 and a large increase in superoxide 
levels.  In regions of chronically disturbed flow, superoxide levels were moderately 
increased, while expression of cellular adhesion molecules, both VCAM-1 and ICAM-1 
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was significantly increased.  Additionally we show that fatty streaks form in the region 
downstream from the coarctation over a chronic time course.  From these results we 
determined two main conclusions. 
We conclude that the in vivo endothelial phenotype associated with acutely 
disturbed flow is characterized by increased production of superoxide and increased 
expression of select inflammatory proteins. In comparison, the phenotype associated with 
chronically disturbed flow is characterized by a more modest increase in superoxide and 
increased levels of multiple inflammatory proteins.  
We used a novel superoxide sensitive dye, hydro-cyanine 3, to quantitatively 
measure endothelial superoxide levels in regions of acutely and chronically disturbed 
flow.  The current gold standard for superoxide detection in tissue is with DHE staining; 
however, DHE requires complex purification prior to use, it has a short half life, and it is 
light sensitive.  Therefore, we used the hydro-Cy3 dye, which is more stable than DHE, 
to measure regional tissue levels of endothelial superoxide [58].   We found that 
superoxide levels increase significantly in regions of low magnitude oscillatory WSS as 
compared to regions of high unidirectional WSS, similar to published data from in vitro 
studies [59, 60, 66-68].  Contrary to these results, there was only a moderate increase 
under chronically disturbed flow.   
Transcription factors are similarly transiently expressed and activated in response 
to low magnitude oscillatory WSS [98, 99, 101].  Our results show no significant change 
in NFκB expression in either the chronic or acute time course.  Our findings are 
contradictory to previous studies that found increased p65 expression in “high prone” 
regions near the aortic sinus and inner curvature of the arch [101, 124].  Hajra et al. 
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additionally reported that an additional stimulus, either LPS treatment or high fat diet, 
resulted in the activation and translocation of NFκB to the nucleus and this response was 
only observed in regions prone to lesion formation [101].  Previous in vitro studies had 
reported that low magnitude oscillatory WSS was sufficient to increase p65 expression 
and NFκB activation and that an additional stimulus was not needed.  Other studies have 
further investigated NFκB in relation to lesion formation showing that NFκB deficiency 
in the endothelium results in attenuated lesion area [129].  It is important to note 
however, that blocking NFκB in other cell types resulted in changes in the composition 
within the lesion or even increased lesion formation [130, 131].  These results 
investigating the response of NFκB to WSS and the eventual contribution to lesion 
formation are not consistent with one another.  It is likely that the time course involved 
plays an important role.  A recent mechanistic model predicted that in response to 
oscillatory WSS there was an immediate increase in NFκB activation, which decreased 
by ten hours and increased again by 24 hours [141].  Further analysis of the persistent 
activation and expression of NFκB will be valuable in determining the in vivo response of 
NFκB to WSS and contribution to lesion formation. 
NFκB is one of the primary transcription factors that produce increased 
expression of cellular adhesion molecules.  Our results confirmed the previous findings 
that expression of both VCAM-1 and ICAM-1 is upregulated in the lesser curvature of 
the aortic arch where flow is chronically disturbed [20].  However, we found that 
VCAM-1 expression, and not ICAM-1 expression, is upregulated in response to acutely 
disturbed flow downstream from the coarctation.  VCAM-1 has been shown to be a 
requisite mediator of flow dependent lesion formation in the aortic arch of VCAM-1 
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deficient (D4D) mice [111].  ICAM-1 knockout mice on the other hand, have been shown 
to have reduced lesions throughout the entire aorta but not in regions of flow mediated 
lesion formation [132].  These results along with our results implicate VCAM-1 in the 
early and acute stages of atherogenesis.  Additionally, it suggests that VCAM-1 is a 
requisite mediator for flow induced lesion localization while ICAM-1 is not, though 
ICAM-1 might be involved in later stage lesion formation.  These data could explain our 
results in which we did not observe an acute increase in ICAM-1 expression.   
The results presented in aim II show a distinct difference between the acute and 
chronic response of atherogenic markers in vivo and additionally show differences 
between the in vivo and in vitro settings.  Much of the current literature has been obtained 
using in vitro, cell culture, techniques which often utilize a time course on the order of 
minutes to hours.  Recently, in vitro studies have begun extending the time course of 
experiments to 72 hours allowing the cells to reach what is considered a stable 
equilibrium, though even this is still significantly different from the time course often 
used in vivo [124].  Our coarctation model is able to provide an acute time course similar 
to the 72 hour in vitro studies, as well as the chronic time over the life of the mouse that 
is consistent with most in vivo models.   
The acute and chronic time course from the coarctation and aortic arch models, 
provide insight into slightly different pathologies.  The chronic time course is similar to 
the progression of atherosclerosis.  Atherosclerosis is a multi-stage and multifactoral 
disease that develops over a long time course.  The chronic environment in the lesser 
curvature of the aortic arch has been described as atherosusceptible, though it is in an 
equilibrated and stable state in the absence of other factors.  It is plausible that feedback 
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mechanisms might help to stabilize the system such that it eventually equilibrates as 
opposed to experiencing an amplification of oxidative stress.  This environment is ideal 
for investigating the progression of lesion formation in a flow dependent manner; 
however, it does not accurately represent the mechanotransduction mechanisms in 
response to disturbed flow.  Alternatively, the acute coarctation model better investigates 
the in vivo mechanotransduction of low magnitude oscillatory WSS.  There may still be 
compensatory mechanisms and parallel pathways, that are not present in the in vitro 
setting, though these may be different then temporal compensatory mechanisms observed 
in the chronic model.  Investigating both the acute and chronic response and in particular, 
the compensatory mechnisms that lead to the equilibrated chronic state may provide new 
directions for treatments of atherosclerosis lesion formation. 
 In summary, we present a novel model in which we can compare molecular 
signaling in response to acutely and chronically disturbed flow.  We show that there are 
distinct endothelial phenotypes associated with either chronically disturbed flow or 
acutely disturbed flow.  In conditions of acutely disturbed flow we show and increase in 
superoxide levels and an increase in VCAM-1 expression.  In regions of chronically 
disturbed flow we show a trend for an increase in superoxide levels and a significant 
increase in both VCAM-1 and ICAM-1.  There are still many other mediators of 
mechanosensitive pathways that have been identified in vitro.  These results demonstrate 
the importance of confirming in vitro findings to in vivo settings and in particular to 
consider the involved time course.  This in vivo model additionally allows for the 
investigation of the functional contribution of various mechanosenstivite markers, which 
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we analyzed in the third aim using genetically altered mice and pharmacologic 
treatments.  
Aim III 
We hypothesized that in an in vivo model of low magnitude oscillatory WSS, 
superoxide levels would increase in an NADPH oxidase dependent manner and that this 
increase in superoxide would then mediate shear dependent VCAM-1 expression.  Our 
primary objective was to investigate whether either superoxide or hydrogen peroxide 
mediates the increase in VCAM-1 expression observed in regions of low magnitude 
oscillatory WSS.  Our secondary objective for this aim was to determine the source for 
WSS induced superoxide generation.  We found that tempol was able to reduce 
superoxide levels given that tempol was delivered at a sufficient dose.  Though tempol 
was able to reduce superoxide levels, VCAM-1 still increased in regions of low 
magnitude oscillatory WSS in tempol treated mice.  Additionally, we found that in our 
flow models, p47 phox-/- mice had endothelial superoxide levels and VCAM-1 expression 
that was comparable to the control mice.  Finally, in models of decreased hydrogen 
peroxide levels, we found that VCAM-1 expression still increased in regions of acutely 
disturbed flow.  However, ebselen treatment was able to reduce VCAM-1 expression in 
regions of chronically disturbed flow in comparison to the control.  From these results we 
determined two conclusions. 
We conclude that in regions of acutely disturbed flow in vivo, VCAM-1 
expression is not modulated by reactive oxygen species.  Additionally, we conclude that 
p47 phox-dependent NADPH Oxidase activity does not have a functional role in WSS 
induced superoxide generation in the endothelium.  
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We investigated the mechanisms of shear dependent superoxide formation and in 
particular the in vivo contribution of p47-dependent NADPH oxidase activity.  Previous 
studies found that p47 phox had a functional role in shear dependent superoxide 
formation and subsequent inflammatory protein expression [27, 67, 68, 128].  Our study, 
however, found that in p47 phox-/- mice, superoxide levels increased significantly in the 
downstream region as compared to the upstream region and neither region was 
significantly different from that of the control.  Additionally, VCAM-1 expression in p47 
phox-/- mice was comparable in all regions to the expression in control mice.  Though a 
previous in vivo study showed shear dependent increases in superoxide generation in a 
p47 phox dependent manner, the study may have been measuring superoxide produced 
by additional cell types, such as macrophages or smooth muscle cells [27].  We 
specifically show that endothelial cells do not produce superoxide in response to 
disturbed flow through a p47 phox dependent mechanism.  These results show that in 
vivo endothelial production of superoxide in response to low magnitude oscillatory WSS 
is not p47 phox dependent and suggest the presence of compensatory or parallel 
pathways in vivo.   
p47 phox-/- mice have some clear limitations with regards to analysis of the entire 
NOX family.  The p47 phox subunit is not present in all NOX family members 
particularly NOX 4.  NOX 4 in fact, has been shown to be upregulated in p47 phox-/- 
mice [D. Sorescu, personal communication].  This compensatory mechanism could 
account for the lack of change in superoxide levels and may even produce an additional 
increase in other oxidants, primarily hydrogen peroxide.     
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We then investigated the contribution of superoxide to WSS dependent VCAM-1 
expression.  After confirming the efficacy of tempol treatment, we found that animals 
with attenuated superoxide levels had comparable VCAM-1 expression in the upstream 
and downstream regions when compared to the control.  These data show that superoxide 
does not mediate WSS induced changes in endothelial VCAM-1 expression in the aorta.   
NADPH oxidase family members can directly produce hydrogen peroxide, we 
therefore wanted to investigate whether decreasing hydrogen peroxide levels might 
inhibit inflammatory protein expression.  To analyze the contribution of hydrogen 
peroxide to shear dependent inflammatory protein expression, we utilized ebselen treated 
mice and catalase overexpressing mice.  We found that VCAM-1 expression was not 
attenuated in the downstream region in either catalase overexpressing mice or mice 
treated with ebselen.  We did, however, see attenuated VCAM-1 expression in the 
chronically disturbed flow region in ebselen treated mice.  This level of expression, 
however, was still higher than upstream levels.   A limitation of these experiments is the 
lack of accurate methods for the measurement of hydrogen peroxide, therefore we cannot 
confirm the efficacy of the treatments.  Hydrogen peroxide is challenging to measure in 
vivo and more challenging to measure specifically in the endothelium.  The dye DCF-DA 
is sometimes used to measure hydrogen peroxide levels; however, recent reviews have 
shown evidence for the instability of the molecule [54].   
The last model that we used investigated the contribution of NFκB to VCAM-1 
expression in the coarctation model.  As was the trend in the other animal models, the 
NFκB-/- mice had a significant increase in VCAM-1 expression in the region of acutely 
disturbed flow, comparable to the control.  Studies have previously shown that a shear 
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dependent increase and activation of NFκB occurs through a redox mechanism in vitro 
[127]. Our data, therefore, suggest the presence of an in vivo pathway that is independent 
of NFκB and also independent of redox signaling.  
There were slight differences in the data from aim III in the chronic and acute 
disturbed flow regions.  In the acute disturbed flow region, inflammatory protein 
expression was completely independent from oxidative stress.  This implies that in vivo 
there must be other mechanotransduciton mechanisms by which shear stress is able to 
produce inflammatory protein expression. The data from the chronic region showed a 
trend for attenuated VCAM-1 expression in the downstream region from each of the 
models of decreased ROS, though it only reached significance in the ebselen treated 
group.  We therefore, suspect that ROS do play a role in chronically disturbed flow, but 
other pathways are still activated, whether parallel or compensatory.  It is known that 
oxidative stress contributes to atherosclerosis lesion formation in accelerated 
atherosclerosis mouse models.  However, when specifically considering flow dependent 
lesion formation in regions like the arch, there have been some differing results [69].  
These data suggest that there may be parallel pathways that are activated in a flow 
dependent lesion formation.  These data, along with our data suggest that flow dependent 
lesion localization occurs through a mechanotransduction mechanism independent of the 
redox state.  Future work might therefore investigate parallel or compensatory pathways.   
As a result of this study we conclude that shear dependent inflammatory protein 
expression occurs through a redox independent mechanism.  Superoxide is acutely 
responsive to low magnitude oscillatory WSS, as is VCAM-1.  In this model VCAM-1 
expression is not dependent on superoxide levels.  Furthermore, compensatory 
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mechanisms or parallel pathways appear to exist in vivo in the shear dependent 
production of superoxide, such that this pathway is not dependent on p47 phox.  Though 
in vitro studies can provide valuable insight into molecular mechanisms involved in 
atherogenesis, it is still important to investigate these molecular mechanisms in vivo for 
greater understanding of the development of atherosclerotic plaques.  Finally, we show 
that models of decreased hydrogen peroxide do not inhibit acute shear dependent VCAM-
1 expression, but may attenuate VCAM-1 expression partially in a chronic time course.  
These data suggest that hydrogen peroxide may be involved in VCAM-1 upregulation as 
a result of disturbed flow, but it is not a critical component.  Mechanically induced 
oxidative stress is clearly a complex mechanism and further research is required to 
determine the many pathways that are involved.  
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Limitations and Future Directions 
A major limitation for the first aim was the lack of ability to image the 
morphology in vivo.  We utilized three different imaging modalities, µCT, MRI, and ex 
vivo perfusion, to best approximate the morphology of the aorta surrounding the 
coarctation.  However, the ideal imaging modality would directly measure the aortic 
morphology in vivo.  The most promising direction to achieve this would be in vivo µCT.  
This could theoretically be accomplished by pursuing two different directions.  The first 
would be improved µCT technology.  Investigators have utilized improved algorithms 
that measure the phase shift in X-ray refraction as opposed to attenuation of X-rays to 
obtain better vascular contrast[142].  Additionally, recent advances using flat panel 
detectors have reduced acquisition time and improved sensitivity and signal to noise ratio 
[143, 144].  The second technique would be improved contrast agents.  Investigators have 
been working on developing contrast agents with improved circulating time [145].  There 
is now a commercially available blood pool contrast agent, Fenestra VC (Alerion 
Biomedical, Inc., San Diego, CA), which has been used to image the aorta [146].  
Improved in vivo angiography in mice would have additional applications particularly 
involving imaging of vessels at multiple time points over an extended time course.  This 
could theoretically be used to monitor the progression of diseases such as aneurysm 
formation or monitor angiogensis. 
Though this technology would be immensely useful for numerous applications, 
we do not believe it would alter the outcome of our findings.  We have quite thoroughly 
characterized the hemodynamic environment associated with the aortic coarctation and 
show that it produces a region of low magnitude oscillatory WSS.  Additionally, 
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improved µCT would still have interference from the material of the nitinol and have a 
halo effect distorting the image immediately surrounding the clip.  Nevertheless, this 
would still be a very useful direction for further research. 
Another limitation for the first aim involves the WSS profile, which we wanted to 
be low magnitude and oscillatory WSS.  This WSS profile has been correlated to lesion 
formation.  However, it is unknown which parameters dictate the development of the 
disease.  We characterized our flow environments under two parameters: magnitude, i.e. 
low vs high, and directionality, i.e. oscillatory vs unidirectional.  This is a very basic 
characterization of the stresses that are imparted on the endothelium.  With regards to the 
magnitude it is currently unknown whether this is a simple binary mechanism, such that 
crossing a threshold activates atherogenic signaling.  It is plausible that there is a balance 
between an atherogenic state and an atheroprotective state, and the magnitude can 
gradually shift the phenotype along this scale.  With regards to directionality, there are 
still questions about what constitutes oscillatory or unidirectional.  Flow occurs in three 
dimensions with primary flows that tend to move axially along the vessel and secondary 
flows that move circumferentially.   The shear stress vector is therefore not simply 
forwards or backwards but also includes a second dimension.  Investigators have 
attempted to quantify directionality using the OSI [5, 147, 148].  OSI provides a more 
substantial measure of directionality than simply oscillatory or unidirectional.  Similar to 
the magnitude issue, this raises the question of whether this is a binary mechanism that is 
on or off, or a gradual mechanism that can shift along a scale.  There are also other 
parameters that may be involved in lesion localization, such as the gradient of shear. 
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Improved models that allow for further analysis of the parameters of WSS will be 
valuable in better understanding endothelial mechanotransduction.  The coarctation 
model could be modified to investigate some of these questions using different sized 
clips.  Different sized clips would result in a different degree of stenosis which would 
impart a different WSS profile upon the endothelial cells.  The sensitivity analysis in aim 
I demonstrates this effect (figure 3.22).  With a smaller degree of stenosis there is a 
smaller region of flow separation and a smaller change in magnitude, while a larger 
stenosis would create a larger separation region and a larger change in WSS magnitude.  
Different sized clips could be used to investigate the gradual change in the parameters of 
magnitude, OSI, and gradient of shear.  A different approach to this problem might be to 
step back to the in vitro environment.  There are currently improved cell culture flow set 
ups that allow for excellent control over the WSS profile [149].  Similar cell culture 
systems could allow for improved in vitro analysis of the various parameters of WSS. 
A main limitation for aim II is the access to adequate probes for desired targets.  
The study raises a particular interest in hydrogen peroxide.  As discussed in Chapter 4, 
the dye DCF-DA can be used to measure hydrogen peroxide levels, but DCF-DA is very 
unstable [54].  We show a novel fluorophore that is specific to superoxide, a similar type 
of fluorophore that specifically measures hydrogen peroxide, would also be useful.  Other 
targets of interest for future studies include BMP-4, eNOS, xanthine oxidase, 
peroxynitrite, and AT1R.  The AT1R is of particular interest as a recent study showed that 
AT1R expression increased in atheroprone regions and was blocked in eNOS 
overexpressing mice [140].  Furthermore, we have some preliminary en face data that 
links expression of the AT1R to regions of disturbed flow and AAA formation.  Another 
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target of interest might be micro-RNA.  A collaborator recently showed in vitro that some 
mirs, including mir-21, are regulated in response to WSS.  We are currently working with 
them to develop an en face staining protocol for mir-21 using in situ hybridization.  
Another limitation for aim II was the determination of a time course.  We 
originally determined 72 hours from a pilot study in which we measured VCAM-1 
expression after numerous time points.  All time points in our pilot study showed 
increased VCAM-1 expression with little variability.  However, other markers are likely 
to have more variability, particularly NFκB.  NFκB is believed to be very transiently 
expressed and activated.  Therefore 72 hours may not be the optimal time point for the 
measurement of an acute NFκB response.  Additionally, ICAM-1 showed that there was 
a chronic increase in expression but not an acute increase in expression in response to 
low magnitude oscillatory WSS.  We looked at ICAM-1 expression after 7 days with a 
coarctation and still saw no change.  These results raise the question of the difference 
between the chronic and acute phenotype.  It is likely that this is a gradual change in 
which the cell is attempting to equilibrate and reach a stable state.  This would imply that 
there are compensatory mechanisms that are activated and help to stabilize the state of the 
cell.  A future direction could utilize the coarctation model using more time points to 
investigate any compensatory mechanisms.  This information might provide a means not 
only to stabilize atherosclerotic lesion progression but possibly even reverse the 
progression.    
There are a number of limitations for aim III.  The primary limitation of concern 
is the lack of a NADPH oxidase specific inhibitor or knockout model.  NADPH oxidase 
is a primary source of superoxide in the endothelium and has been shown to be 
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responsive to WSS in vitro [67].  We, however, found that superoxide was produced in a 
p47 phox independent manner in regions of low magnitude oscillatory WSS in vivo.  We 
therefore would like to further investigate the source of the superoxide generation in the 
endothelium in response to low magnitude WSS.  Other possible animal models to 
investigate NADPH oxidases could include gp91 phox-/- mice, p22 phox-/- mice or DPI 
treated mice.  Additionally we would like to look at enzymatic ROS sources other than 
NADPH oxidase, primarily uncoupled eNOS.  Using eNOS-/- mice, DPI treated mice, or 
L-NAME treated mice could provide insight into the contribution of uncoupled eNOS to 
endothelial superoxide generation in our model.  Lastly, we would like to use these 
models to investigate other inflammatory markers, particularly ICAM-1.  We found that 
ICAM-1 expression did not increase in the acute model, but did increase in the chronic 
model.  Future directions could investigate this difference and utilize knockout models 
and pharmacological inhibitors to investigate the ICAM-1 response to chronically 
disturbed flow. 
Additionally none of our animal models of decreased ROS looked at 
compensatory mechanisms or parallel pathways.  It would be of interest to utilize a model 
of dual treatments to decrease both superoxide and hydrogen peroxide.  This could be 
done using catalase overexpressing mice treated with tempol or mice treated with both 
ebselen and tempol.  Additionally looking at eNOS models with a secondary treatment 
might give insight into parallel pathways.  Lastly it would be interesting to investigate 
other signaling pathways that may be parallel to the redox signaling pathway.  As 
mentioned previously, the angiotensin pathway is of particular interest.  Other directions 
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might include cytokines such as TNF-alpha or IL-1, or growth factors, such as PDGF all 
of which have been shown to increase in response to disturbed flow (REF). 
  Additional future directions might investigate the coarctation model as it relates to 
atherosclerotic lesion formation.  Previous future directions discussed the time course 
between acute and chronic oxidative stress and inflammatory protein expression.  The 
next progression in the time course would be to the beginning of lesion formation.  After 
lesion formation is intiated there are a series of events that result in the progression of the 
lesion, but little is understood about the contribution of WSS to this progression.  We 
have shown that superoxide can be decreased in the regions of low magnitude oscillatory 
WSS, but that this does not alter VCAM-1 expression.  A future direction could 
investigate whether a decrease in superoxide, but not VCAM-1, would be sufficient to 
attenuate lesion formation.  Additionally, it would be interesting to investigate the 
contribution of WSS after the intitiaon of lesion formation, by removing the nitinol clip at 
various time points part of the way through the lesion formation study.   This model 
could be used to distinguish whether disturbed flow continues to be involved in middle 
and later stages of lesion formation, or if it is only involved in the initiation and 
localization of the disease.   
A final future direction might utilize the coarctation model to investigate the 
mechanical environment that contributes to aneurysm formation.  There are many 
similarities between abdominal aortic aneurysm formation and atherosclerosis formation.  
Both are focally localized diseases, though they localize to different regions.  It is 
believed that flow disturbances might contribute to AAA formation.  Preliminary data 
from our lab showed that AT1R was upregulated at the celiac branch where there were 
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flow disturbances.  Aneurysms form in AngII treated animals at this same location.  It 
would be interesting to see if other factors could shift the balance of the coarctation 
model from atherosclerosis formation to aneurysm formation.  A possible means to do 
this might be treatment with the lysyl oxidase inhibitor βAPN.  This would prevent 
crosslinking of the extracellular matrix which in combination with the mechanical 
inflammatory and oxidative stimulus produced by the coarctation might produce an 
aneurysm.  A separate direction related to aneurysm formation might be to use the clip as 
a therapeutic.  Placing the clip around the aorta of the mouse provides a mechanical 
support for the vessel wall.  This might be able to be used to prevent or treat aneurysm 
formation when the vessel wall loses mechanical integrity. 
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Conclusion 
 The overall objective for this thesis was to develop an in vivo flow model that 
produces low magnitude oscillatory WSS.  To achieve this objective, we created a novel 
aortic coarctation model using a shape memory nitinol clip.  The clip reproducibly 
constricts the aorta creating a narrowing of the lumen resulting in a stenosis.  This 
mechanical constraint produces a region of flow separation downstream from the 
coarctation.  We have characterized the coarctation in terms of the efficacy, pressure loss, 
and fluid dynamics.  We then measured the endothelial response of shear sensitive redox 
and inflammatory markers.  Lastly, we utilized genetically modified mice and mice 
treated with pharmacological inhibitors to investigate the mechanisms involved in the 
expression of WSS induced inflammatory and redox markers.  From these experiments 
we have reached the following conclusions: 
1) Coarctation of the descending aorta using a nitinol clip uniquely created a 
hemodynamic environment of low magnitude oscillatory WSS without a 
significant change in blood pressure.   
2) The in vivo endothelial phenotype associated with acutely disturbed flow is 
characterized by increased production of superoxide and increased expression 
of select inflammatory proteins. In comparison, the phenotype associated with 
chronically disturbed flow is characterized by a more modest increase in 
superoxide and increased levels of multiple inflammatory proteins. 
3) In regions of acutely disturbed flow in vivo, VCAM-1 expression is not 
modulated by reactive oxygen species.  Additionally, we conclude that p47 
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phox-dependent NADPH Oxidase activity does not have a functional role in 
WSS induced superoxide generation in the endothelium.  
In summary, we have created a novel murine model of low magnitude oscillatory 
WSS that can be used to investigate the in vivo molecular mechanisms associated with 
atherogenesis. While previous data obtained in vitro indicated that depletion of an 
individual ROS was sufficient to inhibit flow-induced inflammatory protein expression, 
our findings, to the contrary, showed that antioxidant treatment in vivo does not inhibit 
shear-dependent inflammatory protein expression.  Our results suggest that atherogenesis 
in the in vivo environment is significantly more complicated than the in vitro 
environment and that parallel pathways and compensatory mechanisms are likely 
activated in vivo in response to WSS.  These results could have significant implications in 
the efficacy of antioxidant treatment of atherosclerosis and could explain the complexity 





HYDRO-CY3 STAINING PROTOCOL 
 
1. Prepare hydro-Cy3 for pressure perfusion 
a. It is preferable to use freshly made dye (made within a week or so) – when 
you break the seal and open the bottle you want to see minimal pink (some 
is ok but it should not be bright pink) 
b. Dissolve hydro-Cy3 in methanol to a final stock concentration of 1 mg/ml 
c. I use a working dilution of:   500 uL stock hydro-Cy3: 100 mL saline 
2. Fill a Viaflex IV bag (250 uL) with the above solution and cover with aluminum 
foil 
3. Sacrifice mouse with CO2 – expose heart and place a butterfly needle in the left 
ventricle 
4. Pressure perfuse @ 100mmHg using Viaflex IV bags 1m above the mouse (turn 
off the lights in the room - though hydrocyanine  is stable it is still somewhat light 
sensitive) 
a. Perfuse for 5 min with saline 
b. Perfuse for 5 min with working dilution hydro-Cy3 as described above 
(note: hydro-Cy3 is membrane permeable and detergent is not needed) 
c. Perfuse for 5 min with 10% formalin 
d. Perfuse for 5 min with saline 
 
5. Harvest the aorta  
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6. Wash aorta in PBS in a 24 well plate until visibly clean (i.e. no blood), and then 
mount en face in Vectashield mounting medium w/DAPI 
7. Control   
a. Negative control – Add a pressure perfusion step after the first saline wash 
and before the hydro-Cy3 with tempol.  Perfuse with tempol at 5mM for 5 
min. 
b. Positive control - Treat the mouse with 0.5 mg LPS the evening before 




AORTIC COARCTATION SURGERY PROTOCOL 
Materials 
 
1. Small surgical scissors 
2. Hemostat forceps 
3. 2 small, micro-forceps 
4. Self retaining retractors 
5. Nitinol Clip 
Procedure 
 
1. Sterilize instruments with glass bead sterilizer. 
2. Anesthetize mouse -  oxygen delivered through inhalation at a flow rate of 
0.5L/min mixed with isoflurane at 3% for induction and 1.5% for maintenance. 
3. Shave the abdomen of the mouse. 
4. Remove the remainder of hair in this region with depilatory cream (Nair). 
5. Wipe skin with gauze to remove excess cream and hair and then cleanse skin with 
6. Betadine. 
7. Make a single incision along the midline of the skin and peritoneum of the 
abdomen. 
8. Expose the abdominal cavity using a self-retaining retractor to push open the skin 
and peritoneum. 
9. Locate the abdominal aorta using a dissecting microscope.  Remove the 
peridaventitial fatby performing a blunt dissection with the micro-forceps.  Push 
the micro-forceps underneath the aorta to ensure a clear path for the clip. 
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10. Deform the clip to an open state and insert underneath the aorta. The clip should 
recover to its orginal state, but warmed saline can help assist the process if 
needed. 
11. Return the intestines to the abdominal cavity and suture the peritoneum and skin 
together with absorbable sutures. 
12. Apply surgical staples along the incision line to ensure proper healing. 
13. Keep animals on a heating pad during recovery and give buprenorphine (0.01 
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